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Abstract
The lampricide 3-trifluoromethyl-4-nitrophenol (TFM) is applied to tributaries of
the Great Lakes to control invasive sea lampreys (Petromyzon marinus). Although
TFM is selectively toxic to larval sea lampreys, non-target mortality can occur during
lampricide treatments. It is important to know whether or not TFM played a role in
the death of these fishes, and the most direct means to do this is using forensic
science principles. The objectives of this study were to: (i) determine the acute
toxicity of TFM to the non-target fishes, rainbow trout (Oncorhynchus mykiss) and
white sucker (Catostomus commersonii), and how the lampricide is distributed in the
blood, liver and white muscle of these fishes, (ii) establish concentrations in the
blood and tissues that could cause death to non-target fishes, and (iii) ascertain the
most appropriate methods of blood and tissue sample storage and preservation for
the investigations of non-target mortality. TFM concentrations and relative amounts
of TFM-metabolites were measured in the blood and tissues of the non-target fish
using LC-MS/MS following exposure to their 9-h LC25 for 6 h. Data showed that
rainbow trout had a 12-h LC50 of 13.3 mg l-1 compared to a value of 15.0 mg l-1 for
white sucker and that TFM concentrations for both species were by far the greatest
in the liver, which is well supplied with blood and also equipped with organic anion
transporters which transport xenobiotics such as ionized TFM into hepatocytes. At
lethal exposure concentrations, a “spill-over” effect was observed characterized by
TFM concentrations that exceeded the detoxification capacity of the liver, leading to
significantly increased concentrations in the blood and muscle, compared to those
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measured at sub-lethal exposure concentrations. The testing of various storage
methods on the stability of TFM and its metabolites in blood and tissues showed
that while liver accumulated the greatest amount of TFM, it was also prone to large
changes in both parent TFM and its metabolites at sub-optimal storage conditions
for lengths of time greater than 1 h. Concentrations of TFM were most stable in
muscle, likely due to its relative lack of detoxification enzymes and isolation from
the microbes of the gastrointestinal tract. The present study demonstrates that, if
possible, liver, white muscle, and whole blood should be collected from non-target
fishes following unexplained mortality and although quick freezing using liquid N2
or dry ice and longer-term storage at temperatures lower than -20˚C is optimal,
keeping samples on ice or at room temperature for no longer than 1 h can yield
lampricide measurements of reliable quality.
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Chapter 1: General Introduction
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History of Sea lamprey (Petromyzon marinus) in the Great Lakes
The sea lamprey (Petromyzon marinus) is a jawless fish that spends the first
3-7 years of its life burrowed in the sediment of streams and rivers as filter-feeding
larvae before metamorphosing into juvenile parasitic lampreys, which feed on the
blood of teleost fish (Beamish and Potter, 1975; Potter, 1980; Youson, 2003).
Metamorphosis involves physiological changes such as the development of eyes, a
buccal funnel with teeth and a rasping tongue, and the re-organization of gills and
internal organs (Youson, 1980). After metamorphosis the juvenile sea lamprey
migrates downstream to larger bodies of water such as the ocean or the Great Lakes,
in the case of anadromous or landlocked populations, respectively, where they begin
their juvenile blood feeding parasitic stage (Beamish and Potter, 1975; Youson,
1980; Farmer et al., 1975). After 12-20 months in the parasitic phase, during which
a single lamprey may kill up to 18 kg of lake trout (Salvelinus nemaychus; Swink,
2003), the adult sea lamprey then migrates back to freshwater streams to spawn
and then die (Applegate, 1950; Beamish and Potter, 1975; Halliday, 1991).
Although sea lampreys are not native to the Great Lakes there is evidence of
their presence in Lake Ontario in the 1800’s (Radforth, 1944; Scott and Crossman,
1947; Lark, 1973). The invasion of Lake Erie is thought to have occurred in the
1920’s following modifications to the Welland Canal, which allowed the lampreys to
by-pass the natural barrier provided by Niagara Falls (Radforth, 1944; Christie,
1974). The invasion into the remaining Upper Great Lakes in the early 20th century,
in combination with pollution and overfishing, lead to the decline of native teleost
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fish populations such as the lake trout (Smith and Tibbles, 1980), triggering the
collapse of commercial and recreational fisheries (Lawrie, 1970; Christie, 1974).
In 1946, the Great Lakes Sea Lamprey Committee was founded as a joint
effort between the Canadian and American governments to develop measures to
control sea lamprey populations in the Great Lakes (Lawrie, 1970; McDonald and
Kolar, 2007). Initial control efforts, including electrical and physical barriers, were
generally successful in preventing the upstream migration of spawning adult sea
lamprey, but this also caused harm to non-target fish populations by interfering
with their movements (Smith et al., 1974; Smith and Tibbles, 1980).
Lampricides
In the 1950s, after testing over 6,000 different chemicals, 3-trifluoromethyl4-nitrophenol (TFM; Figure 1-1) was discovered to selectively target larval sea
lampreys at concentrations that were much less toxic to most non-target organisms
(Applegate et al., 1961; Hubert, 2003). Later it was discovered that when mixed with
TFM, the molluscide niclosamide (aka Bayluscide; at 0.5-2% of the TFM
concentration) significantly reduced the amount of TFM needed to treat a river or
stream without reducing the selectivity to larval sea lamprey (Howell, 1964;
Associate Committee on Scientific Criteria for Environmental Quality, 1985).
Currently, an integrated sea lamprey control program overseen by the Great Lakes
Fisheries Commission (GLFC) includes traps and dams to prevent adults from
migrating upstream to spawn (Lavis et al., 2003), the release of sterile males to
compete with fertile males (Twohey et al., 2003), and applications of the
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lampricides to streams and rivers containing populations of larval sea lampreys
(Applegate, 1961; McDonald and Kolar, 2007).
Many non-target fish species including rainbow trout (Oncorhynchus mykiss),
and white sucker (Catostomus commersonii) are found in the tributaries of the Great
Lakes and can be exposed to the lampricides (Scott and Crossman, 1974; National
Research Council of Canada, 1985). This poses a challenge for the sea lamprey
control program to minimize negative effects on non-target organisms, while also
minimizing residual lamprey populations that survive a lampricide treatment
(Boogaard et al., 2003). The concentrations of TFM and niclosamide that are applied
during sea lamprey control treatments are based on previous reports of the
Minimum Lethal Concentration (MLC) required to kill 99.9% of larval sea lamprey
during a 9 hour exposure (9-h LC99.9; Brege et al., 2003), but are typically 1.2 to 1.5
times the MLC to reduce the risk of larval lampreys surviving the treatment (Bills et
al., 2003; McDonald and Kolar, 2007). In the past, the concentration of TFM was
adjusted to 1.0 times MLC when sensitive, non-target fish species such as larval lake
sturgeon (Acipenser fulvescens) are present in the stream (Boogaard et al., 2003;
McDonald and Kolar, 2007). But this practice was discontinued due to unacceptably
high numbers of residual larval lamprey that survived treatment, which
subsequently metamorphosed and migrated downstream to the Great Lakes (Sutton
et al., 2003; Dobiesz et al., 2018)
TFM Toxicity and Metabolism
TFM exerts its toxic effects by uncoupling oxidative phosphorylation in
mitochondria (Niblett and Ballantyne, 1976; Birceanu et al., 2011). A study by
4

Birceanu et al. (2011) concluded that TFM acts as a protonophore, effectively
causing a decrease in the proton motive force, which is used to drive ATP
production via ATP synthase in the inner mitochondrial membrane (Figure 1-2).
The work built on previous studies suggesting that TFM caused a mismatch between
adenosine triphosphate (ATP) supply and demand after it was found that glycogen
and phosphocreatine levels in the brain and other tissues of larval sea lamprey
dropped significantly after exposure to TFM (Wilkie et al., 2007; Birceanu et al.,
2009). These effects are caused by the decline in ATP production that leads to
greater reliance on anaerobic metabolism, which uses up energy molecule reserves
like phosphocreatine and glycogen, possibly leading to neural starvation and death
(Birceanu et al., 2009; Clifford et al., 2012; Henry et al., 2014).
Compared to non-target fish, larval sea lampreys are more sensitive to TFM
because of their lower capacity to detoxify the lampricide using glucuronidation and
sulfation (Lech and Statham, 1975; Kane et al. 1994). The hepatic enzymes uridine
diphosphate glucuronsyltransferase (UDPGT) and phenol sulfotransferase (PST)
catalyze the attachment of glucuronic acid (Lech and Costrini, 1972; Lech et al.,
1973; Clark et al., 1991; Kane et al., 1994) and sulfonate (James, 1987; Bussy et al.,
2017a), respectively to the lipophilic TFM, creating a more hydrophilic metabolite
that is easier to excrete (Figure 1-3A, 1-3B). In contrast to sea lamprey, most nontarget fishes have higher UDPGT activity and greater UDPGT affinity for TFM (Kane
et al. 1994). Although the major metabolite of TFM detoxification is known to be the
glucuronide conjugate (Lech and Costrini 1972; Lech et al. 1973; Kane et al. 1994),
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the sulfate conjugate has also recently been identified in rainbow trout by Bussy et
al. 2017b.
The toxicity of TFM is inversely related to water pH (LeMaire, 1961; Bills et
al. 1988), and with a dissociation constant (pKa) of approximately 6.07 (Smith et al.
1960; Hubert, 2003), its toxicity is roughly 5 times greater at pH 7 than at pH 8
(McDonald and Kolar, 2007). As water pH goes down, a greater proportion of TFM is
in its lipid-soluble, un-ionized form making it easier for the TFM to diffuse down its
concentration gradient across the gill epithelium, resulting in greater toxicity due to
higher rates of accumulation (Figure 1-1; Hunn and Allen, 1974; Mcdonald and
Kolar, 2007; Hlina, 2015).
Non-Target Mortality
The toxic effects of TFM occur when an animal’s capacity to eliminate the
lampricide is overwhelmed (Lech and Statham, 1975). Although most non-target
fish can tolerate TFM concentrations up to five times higher than is required to kill
larval sea lamprey (Boogaard et al., 2003), mortality can occur during lamprey
control treatments after sudden, drastic drops in water pH (Bills et al. 2003) due to
aerobic respiration by aquatic vegetation and algae, precipitation or agricultural
runoff (Wetzel, 1983; Poudel et al., 2013). Accordingly, stream characteristics like
water flow and pH are monitored during TFM treatments, and TFM application can
be altered following changes in water pH. However, non-target mortality can also
result from unrelated events such as contamination, disease, or natural
environmental stressors such as high temperatures and/or oxygen deprivation due
to high rates of plant respiration or the decomposition of decaying organic matter
6

following events such as algal blooms (Meyer and Barclay, 1990). In many cases,
causes of non-target mortality following lampricide treatments can be determined
by closely monitoring water chemistry and flow, but may go unnoticed due to time
of day, location or weather conditions. When unexplained non-target fish mortality
coincides with lampricide application, and the causes of the fish kill are unclear,
forensic toxicology approaches could potentially be used to deduce the cause of
death, but to date the information needed to conduct such investigations are lacking.
Current Investigation Protocols and Room for Improvement
Currently, there are three levels of impact that describe the severity of a nontarget fish kill. The American Public Health Association (APHA) defines a minor kill
as less than 100 fish found dead within 1.6 km, a moderate kill as 100-1000 fish
found dead within 1.6 km, and a major kill as more than 1000 fish found dead within
1.6 km (as cited by The Great Lakes Fishery Commission, 2016). Investigations for
minor fish kills include filling out collection forms for reporting a number of
different water quality parameters and stream assessment characteristics, while in
the case of a moderate or major fish kill when the cause of mortality is unexplained,
an investigation must be carried out which will include the collection of water and
biological samples for lampricide measurements. While the aim of the investigation
is to determine the cause of the fish kill, gaps exist in how to collect, preserve and
store samples during the pre-analytic phase (Butzbach, 2010) of the investigation
that precedes sample processing and analysis. The overarching goals of my thesis
were to (i) determine tissue concentrations of TFM that could cause death in nontarget fishes, (ii) identify the key metabolites associated with TFM exposure, and
7

(iii) to determine the most appropriate methods of tissue collection, preservation
and storage to be used in forensic investigations of unexplained fish kills during or
following TFM applications.
The current protocols set in place by the U.S. Fish and Wildlife Service (FWS)
and The Department of Fisheries and Oceans Canada (DFO) can be found in the
Great Lakes Fishery Commission standard operating procedures (TOP:026.). Briefly,
it includes the collection of blood, muscle and liver from 20 fish of each species of
fish found dead and storage on ice or on dry ice if it is available, while samples are
delivered to the Upper Midwest Environmental Sciences Centre (UMESC). While it is
well known that for measurements of analytes in tissue samples, the best protocol is
to keep tissues samples as cold as possible to prevent degradation and subsequent
decomposition of analytes (Wang et al. 1994; Hubert et al. 2001; Butzbach, 2010),
sea lamprey control agents in the field might not always have access to these
resources. In cases where optimal storage is not possible, it is important to know
how stable TFM and its metabolites will be in the tissues that are collected and how
different storage conditions can affect the reliability of the measurements. After
death, there are numerous biochemical processes that occur within tissues, which
may have undesirable effects on the concentration of TFM and its metabolites.
Enzymatic processes in tissues do not stop immediately after death, and enzymes
responsible for metabolism of TFM and its metabolites could result in concentration
changes (Butzbach, 2010). Further, all tissues contain different types and amounts
of enzymes due to their specific roles in the bodies of the fish. For instance, liver is
known to accumulate drugs due to its role in the detoxification of xenobiotics
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(Anhalt et al. 1981; James, 1987; Clark et al. 1991; Skopp, 2010), therefore the
presence of metabolic enzymes suggests this tissue will be more prone to
decomposition than other tissues such as white muscle, leading to changes in
concentration (Paterson, 1993; Skopp, 2004). Because TFM applications may take
place in relatively remote locations, where sampling and storage conditions may be
sub-optimal, it is important to know how different handling and storage conditions
affect postmortem lampricide concentrations and to establish parameters about
how long tissues are viable for relevant forensic toxicological analysis. Forensic
science is defined as the use of scientific principles and techniques for the collection,
examination, and analysis of evidence for legal investigations (Forensic science,
2018). Due to the potential legal implications of a large-scale fish kill, it is critical
that tissue samples are handled and stored properly, and the chain of custody be
followed in order to minimize the risk of unreliable measurements.
Thesis Objectives
My thesis will address the following objectives:
I. Determine the acute toxicity of TFM to the non-target fishes, rainbow trout
and white sucker and determine the distribution of TFM and its metabolites
in blood and tissues of these fish (Chapter 2).
II. Establish concentrations of TFM in blood and tissues that could cause
death in rainbow trout and white sucker exposed to lethal concentrations
(Chapter 2).
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III. Ascertain what methods of blood and tissues sample preservation and
storage are most appropriate for investigating incidents of non-target
mortality in rainbow trout and white sucker (Chapter 3).

To determine the acute toxicity of TFM to rainbow trout and white sucker, I
conducted acute toxicity experiments, which were then followed by a series of
experiments in which both species were exposed to known concentrations of TFM,
followed by quantification of how much TFM accumulated in the liver, muscle and
blood of the fishes that survived the TFM exposure. Objective two was investigated
by exposing both species to a range of sub-lethal and lethal concentrations of TFM
followed by quantification of TFM in the liver, muscle and blood immediately
following death or after 12 h of exposure. Lastly, objective three was determined by
exposing both species to known concentrations of TFM and analyzing liver, muscle
and blood samples for quantification of TFM following various storage and
preservation methods for periods of one hour and one week.
Liver, muscle and blood samples of the fishes were analyzed at the Upper
Midwest Environmental Sciences Centre (UMESC), in La Crosse, Wisconsin, U.S.A. for
TFM concentrations, along with the relative amounts of the TFM metabolites, TFMglucuronide and TFM-sulfate using LC-MS/MS.
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Figure 1-1. Dissociation equilibrium of 3-trifluoromethyl-4-nitrophenol
(TFM). TFM is a weak acid with a pKa of 6.07. At a pH lower than 6.07, the
equilibrium of TFM shifts towards the un-ionized phenolic form (left), while at a
pH higher than 6.07, the equilibrium shifts towards the ionized, phenolate form
(right; Hunn and Allen, 1974).
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Figure 1-2. Mitochondrial oxidative phosphorylation. Simplified diagram of
mitochondrial ATP production by oxidative phosphorylation. Protein complexes,
I, III, and IV, located in the inner mitochondrial membrane, pump protons across
the membrane using energy released from passing electrons through the
electron transport chain (ETC). This creates a proton gradient (proton motive
force) and allows protons to flow down the gradient, back into the matrix via
ATP synthase, which harnesses the released energy by phosphorylating ADP into
the high energy molecule ATP.
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Figure 1-3. Structure and detoxification of 3-trifluoromethyl-4-nitrophenol
(TFM). Detoxification via (A) glucuronidation and (B) sulfation. Uridine
diphosphate glucuronsyltransferase (UDPGT) catalyzes the addition of
glucuronic acid from uridine diphosphate glucuronic acid (UDPGA) to TFM to
form TFM-glucuronide (Clark et al. 1991). Phenol sulfotransferase (PST)
catalyzes the addition of sulfate from adenosine 3’-phosphate 5’phosphosulphate (PAPS) to TFM to form TFM-sulfate (Bussy et al. 2017b).
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Chapter 2:
Toxicity, Distribution, and Detoxification of 3-Trifluoromethyl-4-Nitrophenol
(TFM) in Two Non-Target Fish Species
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Introduction
The piscicides 3-trifluoromethyl-4-nitrophenol (TFM) and niclosamide are
applied to tributaries of the Great Lakes to control invasive and parasitic sea
lampreys (Petromyzon marinus; Applegate et al., 1957; Applegate et al., 1961;
Howell, 1964; Smith and Tibbles, 1980; Hubert, 2003; McDonald and Kolar, 2007).
TFM selectively targets larval sea lampreys due to their lower capacity to detoxify
the lampricide via phase two metabolic reactions including glucuronidation and
sulfation, compared to non-target fishes (Lech, 1974; Lech and Statham, 1975; Kane
et al., 1994; Bussy et al., 2017b). The hepatic enzymes uridine diphosphate
glucuronsyltransferase (UDPGT) and phenol sulfotransferase (PST) facilitate the
addition of glucuronic acid (Lech and Costrini, 1972; Lech et al., 1973; Kane et al.,
1994) and sulfate (Bussy et al., 2017a), respectively, to the lipophilic TFM, making it
more hydrophilic and easier to excrete via bile or urine. Yet, non-target mortality
can occur if the bioavailablility of TFM increases as a result of changes in water pH
or over-application of the lampricide (Boogaard et al., 2003; O’connor et al., 2017)
With a pKa of 6.07, the toxicity of TFM is inversely related to pH in both sea
lamprey and non-target fishes, which increases TFM bioavailability by increasing
the proportion of TFM that is present in its un-ionized (phenolic) form, compared to
its ionized (phenolate) form (Hunn and Allen, 1974; McDonald and Kolar, 2007). In
its un-ionized form, TFM is more lipophilic making it easier to be taken up via the
gills, resulting in a greater rate of accumulation (Hunn and Allen, 1974; Hlina et al.,
2017).
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Although non-target fish can typically tolerate TFM concentrations 3-5 times
higher than is required to kill larval sea lamprey (Boogaard et al., 2003), mortality
can occur after sudden, decreases in water pH (Bills et al., 2003). This may occur as
a result of precipitation, agricultural runoff, or and aerobic respiration by aquatic
vegetation and algae (Wetzel, 1983; Poudel et al., 2013). For this reason, water pH
and flows are continuously monitored during TFM treatments, and TFM application
is adjusted in response to changes in water chemistry or pH. However, fish kills can
also arise due to the release of contaminants into the waterways, disease, or natural
environmental stressors related to high temperatures and/or oxygen deprivation
resulting from high rates of plant respiration or the decomposition of decaying
organic matter following events such as algal blooms (Meyer and Barclay, 1990).
Because non-target mortality can arise from a variety of causes, there may be
situations in which it is necessary to ascertain what, if any, contribution TFM may
have made to the unexplained deaths of fishes.
The most direct means to ascertain if TFM contributed to unexpected
incidences of mortality in fishes is to measure the concentrations of TFM and/or its
metabolites in different tissues collected from the animals. To successfully employ
this forensic toxicology approach, it will be important to develop reproducible and
accurate methods of TFM and TFM-metabolite analysis, identify which tissues are
the most reliable indices of TFM and/or TFM-metabolite concentration, and how
best to collect, handle and preserve the tissues prior to analysis. It will also be
important to identify appropriate model fish species that can be used for such
studies.
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Two fishes that could be exposed to TFM during lamprcide treatments are
the rainbow trout (Oncorhynchus mykiss) and white sucker (Catostomus
commersonii), which are both widespread in the Great Lakes basin (Scott and
Crossman, 1973). The toxicity of TFM to rainbow trout is well defined (Lech and
Costrini, 1972; Lech et al., 1973; Lech, 1974; Lech and Statham, 1975; Hunn and
Allen, 1974; Birceanu et al., 2014), but less is known about how TFM affects white
sucker. Both white sucker and rainbow trout non-target mortality have been
recorded during and following TFM application (Smith and Tibbles, 1974; Rossi,
1999; Dahl and Mcdonald, 1980).
The goal of the present study was to characterize how TFM and its
metabolites are distributed in different tissues of the rainbow trout and white
sucker and to determine concentrations of TFM in the blood and tissues that could
cause death to non-target fishes exposed to lethal concentrations. First, to
determine the relative sensitivity of rainbow trout and white sucker to TFM, I
conducted acute toxicity experiments comparing rainbow trout to white sucker.
These experiments were followed by a series of experiments in which both species
were exposed to known concentrations of TFM, followed by quantification of how
much TFM accumulated in the liver, muscle and blood of the fishes. Rainbow trout
were also exposed to a range of sub-lethal and lethal concentrations followed by
quantification of TFM in the blood and tissues. The concentrations of TFM were
measured using LC-MS/MS, along with the relative amounts of the TFM metabolites,
TFM-glucuronide and TFM-sulfate.
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Material and Methods
Experimental Animals and Holding
Rainbow trout were purchased from Rainbow Springs Trout Hatchery
(Thamesford, Ontario) and white suckers were captured by seine netting from
Canagagigue Creek, Elmira, Ontario. Prior to importing the white suckers into
Laurier’s fish holding facilities, the white suckers were treated for ectoparasites in a
formalin bath (0.75% formalin; SOP I23 - Wilfrid Laurier Animal Care Committee).
Both the trout and white sucker were held in separate 800 L holding tanks in Wilfrid
Laurier’s Centre for Cold Regions and Water Science, each tank receiving a mixture
of reverse osmosis water and de-chlorinated, City of Waterloo tap water (pH ~ 8.0,
alkalinity ~150 mg l-1 as CaCO3, temperature ~15˚C). Rainbow trout were kept in a
~2000 L recirculating system, equipped with mechanical and UV filtration. The
water supplied to white suckers was drained directly to waste to prevent mixing of
water with that supplying other fish in the facility. Rainbow trout were fed with
EWOS 3mm floating pellets and white suckers were fed a mixture of bloodworms
and EWOS #1 micro crumble feed three times per week to satiation. Fish were held
for at least two weeks but food was withheld for approximately 72 h before
commencing experiments to minimize build-up of ammonia. Both groups of fish
were held under a 12 h light and 12 h dark photoperiod. All fish husbandry and
experiments were approved by the Wilfrid Laurier University Animal Care
Committee and followed guidelines of the Canadian Council of Animal Care (CCAC).
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Experimental Protocol
Series 1 - Determination of the Acute Toxicity of TFM to Rainbow Trout and White
Sucker
The 12-h LC50, the concentration of TFM required to kill 50% of the exposed
animals over 12 hours, was determined in acute toxicity experiments. The TFM
exposures were conducted in de-chlorinated tap water by exposing groups of
rainbow trout (9.2 ± 0.3 g, 8.8 ± 0.1 cm) to a range of nominal TFM concentrations
between 5 and 30 mg l-1, while white sucker (22.1 ± 3.3 g, 10.6 ± 3.5 cm) were
exposed to a range of TFM concentrations between 2 and 32 mg l-1. Field
formulation TFM (35% active ingredient dissolved in isopropanol; Clariant SFC
GMBH WERK, Griesheim, Germany), provided courtesy of Fisheries and Oceans
Canada (DFO), was used for all toxicity and TFM exposure experiments. The night
before experiments, appropriate amounts of TFM were added to 12 L glass aquaria
filled with aerated water. The TFM concentrations were verified immediately
following TFM addition, and the next morning by spectrophotometry using a
NovaSpec II spectrophotometer (Pharmacia Biotech, Cambridge, UK) at a
wavelength of 395 nm following Standard Operating Procedures of the Department
of Fisheries and Oceans, Sea Lamprey Control Centre, Sault Ste. Marie, Ontario (IOP:
012.4). Six trout or 5 white suckers were then placed into each aquarium. Rainbow
trout were exposed to each test concentration in triplicate (N = 18 per
concentration), but this was not possible for white sucker which comprised a single
group of N = 5 fish at each test concentration. Water temperature in the aquaria was
controlled by immersing them in a water bath, thermostatted to the appropriate
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temperature using an in-line chiller (Coralife ¼ HP Aquarium Chiller, Franklin, WI)
connected in series to a lower reservoir. Dissolved oxygen (DO; > 90 % saturation),
temperature (rainbow trout = 17.3 ± 0.01˚C; white sucker = 11.7 ± 0.09˚C), pH
(rainbow trout = 8.24 ± 0.01; white sucker = 8.15 ± 0.02) and alkalinity (rainbow
trout = 231.4 ± 2.4 mg l-1 as CaCO3; white sucker = 282.2 ± 6.8 mg l-1 as CaCO3) were
monitored throughout the toxicity trials.
Series 2 – Distribution of TFM and its Metabolites in Rainbow Trout and White Sucker
The goal of these experiments were to ascertain how TFM and its metabolites
were distributed in different tissues of larger rainbow trout (N = 10, 199 ± 10 g, 24.8
± 0.33 cm) and white sucker (N = 10, 99.1 ± 9.4 g, 19.49 ± 0.611 cm) following 6 h of
exposure to their approximate 9-h LC25 of TFM, as determined for each species
above. This value was chosen to ensure that the TFM concentration was sufficiently
high to result in measurable accumulation of parent TFM and TFM-metabolites in
different tissues, while minimizing the possibility of partial mortality during
experiments. The 6 h exposure period also provided sufficient time for TFM
accumulation. Birceanu et al. (2014) reported that in rainbow trout exposed to their
12-h LC50, TFM concentration peaked after 3 – 6 h of exposure. Accordingly, an
exposure period of 6 hours was chosen in the present study. It should be noted,
however, that the goal of these experiments was not to determine toxicity, but to
examine the distribution of TFM and its metabolites in a living fish. I therefore used
the acute toxicity data from Series 1 as a guide to determine a suitable concentration
(9-h LC25) to which to expose the fish, without causing mortality over the 6 h
exposure period. The experimental setup was identical for both species, with each
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acclimated overnight to darkened, individual 4 L exposure chambers contained
within a 200 L flow through system continuously receiving dechlorinated, city of
Waterloo tap water at a flow rate of 0.5 liters per minute. Water chemistry and
temperature differed slightly between the experiments (rainbow trout: water pH =
8.5 ± 0.002, T = 15.30 ± 0.05˚C, alkalinity = 255 mg l-1 as CaCO3, DO > 90%; white
sucker: water pH = 8.30 ± 0.02, T = 12.30 ± 0.06˚C, alkalinity = 339 mg l-1 as CaCO3,
DO > 90%). Prior to the addition of TFM, incoming water flow to the system was
shut off to yield a closed re-circulating system in which a submersible pump was
used to pump water from a lower reservoir (~ 70 L) to a head tank (~ 70 L), from
which water drained into the individual exposure chambers of the fish. Based on the
total volume of the system, sufficient TFM was added to achieve the desired TFM
exposure. After 6 h of TFM exposure, all fish were euthanized with an overdose of
tricaine methanesulfonate (MS222; 0.5 g l-1, buffered with 1.0 g l-1 NaHCO3) before
collection of blood, liver and muscle which were snap-frozen in liquid N2 and stored
at -80˚C until processing for quantification of TFM, and characterization of the TFM
metabolites, TFM-glucuronide and TFM-sulfate at the Upper Midwest
Environmental Sciences Centre (UMESC), U.S. Geological Survey, La Crosse,
Wisconsin, U.S.A. Whole blood was collected from the caudal vein/artery by “caudal
puncture” using a sodium heparin coated syringe, with a sub-sample centrifuged at
10,000 x g for 3 minutes to separate plasma from the erythrocytes (red blood cells);
all three fractions (red blood cells, plasma, whole blood) were snap-frozen and
stored at -80˚C as described above for muscle and liver. Due to size constraints, only
whole blood was collected from white suckers.
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Series 3 - Dose-dependent Changes in the Distribution of TFM and its Metabolites in
Rainbow Trout Tissues
To characterize how TFM concentrations in the tissues of rainbow trout
varied with TFM dose, smaller rainbow trout (4.8 ± 0.2 g, 7.1 ± 0.1 cm) were
exposed to a range of nominal TFM concentrations between 5 and 30 mg l-1 over 12
hours, which approximates a typical TFM treatment time. As described above, TFM
was added to 12 L glass aquaria the night before the experiments and TFM
concentrations were verified by spectrophotometry. The next morning, five trout
were placed into each individual aquarium and the experiment was run in triplicate
(N = 15 in total) at each concentration. The pH averaged 8.480 ± 0.004 and alkalinity
averaged 255 mg l-1 CaCO3 over the 12-h exposure. Tissues (blood, liver and muscle)
were collected as described above, immediately following death or after 12 h of TFM
exposure. Tissues were then stored at -80˚C until processing for quantification of
TFM, and characterization of the TFM metabolites, TFM-glucuronide and TFMsulfate.
Analytical Methods
Water TFM Measurements
Water TFM concentrations were measured spectrophotometrically using
either a 96-well microplate spectrophotometer (Epoch 2, Biotek Instruments, USA)
or a standard spectrophotometer (NovaSpec II), using 1.5 mL polystyrene cuvettes.
Samples were measured at wavelength of 395 nm against precision standards as
described above.
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Liver, Muscle and Blood Sample Processing for LC-MS/MS
All blood and tissue samples were processed and analyzed at UMESC.
Aliquots of tissue or blood were pre-weighed (50-100 mg) and transferred to a 2 ml
polypropylene microcentrifuge tube, followed by the addition of 100 µl acetonitrile
containing 1% formic acid to the tube. The contents were homogenized in a SPEX
SamplePrep Geno/Grinder 2010 at 1200 strokes per minute for 90 seconds followed
by the addition of 400 µL of the acetonitrile / 1% formic acid solution before
vortexing the sample for 15 seconds. The samples were cooled at 4˚C for 20 minutes
and then centrifuged for 10 minutes at 12000 x g using a Beckman Avanti 30 High
Speed Compact centrifuge (Ramsay, Minnesota, U.S.A.), and the supernatant was
transferred to Phree phospholipid removal 96-well plates (Phenomenex, Torrance,
California, U.S.A.). The first aliquot was filtered through the Phree cartridge into a 2
ml reservoir well plate by centrifuging at 500 RCF for 5 minutes. The
microcentrifuge tubes were then rinsed with 500 µl acetonitrile + 1% formic acid
and then vortexed and centrifuged as described above. This aliquot was transferred
to the Phree cartridge and then vacuum filtered through into the 2 ml reservoir well
plate for 5 minutes before being centrifuged at 500 RCF for 10 minutes. The
reservoir was then sealed and either immediately injected into the reversed phase
liquid chromatography column (Phenomenex, Kinetex 1.7 µm Evo C18) interfaced
with a quadrupole time of flight mass spectrometry system (Agilent Technologies,
1290 Infinity II LC and 6530 Accutate-Mass Q-TOF LC/MS system) for quantification
of TFM and its metabolites. Unused samples were frozen at -80˚C for later analysis.
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Quantitation of TFM and TFM-metabolites in Liver, Muscle and Blood Samples
The combination of liquid chromatography and mass spectrometry
physically separates the analytes (TFM and its metabolites) and then accurately
identifies the compounds using mass spectrometry. In the present study, an LC
mobile phase with a gradient between solution A (900mL Epure, 100mL MeOH,
385mg ammonium acetate and 0.1% formic acid) and solution B (700mL MeOH and
300mL Isopropanol) was used for the separation of TFM and its metabolites
through the liquid chromatography column over 4 minutes at a flow rate of 0.350 ml
min-1. The gradient was as follows (% of A: % of B; time in minutes): (0.0: 100; 0.0),
(0.0: 100; 2.7), (80:20; 3.0) with column temperature set at 45 °C. The eluent was
then pumped into the mass spectrometer source where it was broken down into
ionized fragments and then accelerated through a vacuum by an electrical field for
analysis based on the mass to charge ratio (m/z) of the ion fragment (Pitt, 2009).
The time-of-flight analyzer measures the time it takes for the ion to reach the
detector, which depends on the m/z ratio because heavier ions reach a lower
velocity. The ion counting detector measures the signal from the ions and a
chromatogram is produced with peaks areas relating to the intensity of signal from
the ions, and thus the amount of ions in the sample (Guilhaus, 1995). By comparing
the relative signal size, the mass/charge ratio vs time of flight against known TFM
standards, the concentrations of parent compounds can be quantified. Due to the
lack of standards for TFM metabolites TFM-glucuronide and TFM-sulfate, a standard
curves could not be generated for these compounds, making it impossible to report
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metabolite concentrations; therefore all measurements of metabolites were
reported in relative peak areas as described by Bussy et al., (2017b).
Calculations and Statistical Analysis
Concentrations of TFM in tissues were determined by applying peak area
counts of the sample to the standard curve equation produced by measuring the
peak areas from standards of known concentration. A dilution factor taking into
account the volume of the extraction solution and homogenized tissue was applied
to the calculated concentration of the sample in ng ml-1. The resulting concentration
in ng g-1 was then converted into nmol g-1 TFM by dividing by the molecular weight
of TFM (207.11 g mol-1). Dilution factors were also applied to the peak areas of the
metabolites TFM-glucuronide and TFM-sulfate. The extraction efficiency of TFM was
calculated in different tissue matrices by spiking the different TFM-free tissues with
a known amount of TFM (spike tissue) and performing the extraction as described
above. Another sample was measured that had the same spike solution of know
concentration but without the tissue (spike null). Extraction efficiency was then
calculated using the equation below:
Extraction Efficiency (%) = Spike tissue (ng/g) X 100 %
Spike null (ng/g)

(1)

A tissue specific extraction coefficient (EC; Table 2-1) was then applied to the
raw TFM concentration measured in each sample in ng ml-1, followed by the dilution
factor (DF) then divided by the molecular weight of TFM to yield the true
concentration of TFM in the tissue in nmol g-1 for muscle and liver or nmol ml-1 for
blood via the following formula:
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Tissue [TFM] = Sample [TFM] X EC X DF
207.11

(2)

Signal area measurements of TFM metabolites in all tissues were normalized
to the highest signal area in liver samples and represented as a percentage.
Lethal concentrations (LC) of TFM were determined by probit analysis
(Sprague, 1969) using R package ‘ecotox’ (Hlina, unpublished). Concentrations of
TFM in tissues were analyzed using either a one-way analyses of variance (ANOVA)
followed by a Tukey Honest Significant Difference post-hoc test when data were
homoscedastic and normally distributed, or a modified students t-test. If these
assumptions were not met (even after transformations; inverse, square root, Log10),
a Kruskal-Wallis rank sum test was performed followed by a Dunn’s test of multiple
comparisons was used. The level of significance was set at a P value ≤ 0.05.
Statistical analysis and figures were produced using R version 3.4.2, RStudio version
1.1.383 (RStudio, 2016), and ‘ggplot2’ (Wickham, 2016). All data are presented as
the mean ± 1 standard error of the mean (SEM).
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Results
Series 1 - Determination of the Acute Toxicity of TFM
The 12-h LC50 to rainbow trout was of 13.3 mg l-1 (CI = 12.4 – 14.4; Figure 22A) and a 9-h LC25 of 13.6 mg l-1 (CI = 11.8 – 15.2). White sucker was slightly more
tolerant to TFM with a 12-h LC50 of 15.0 mg l-1 (Figure 2-2B) and a 9-h LC25 of 18.9
mg l-1. Due to no partial mortalities at 9 or 12 h, 95% confidence intervals could not
be calculated for the white sucker acute toxicity test.
Series 2 - Distribution of TFM and its Metabolites in the Tissues of Rainbow
Trout and White Sucker
TFM-glucuronide eluted from the LC column first at 1.32 min, followed by
TFM-sulfate at 1.65 min and parent TFM at 2.04 minutes (Figure 2-1). Following
exposure to respective concentrations of 12.9 ± 0.1 and 18.3 ± 0.1 mg l-1 TFM (~
their respective 9-h LC25) for 6 h, the greatest TFM concentration was found in the
liver for both rainbow trout and white sucker averaging at 67.5 ± 11.2 nmol g-1 and
210.5 ± 25.8 nmol g-1 wet weight, respectively (Figures 2-3A and 2-4A). Muscle
contained much less TFM, however, averaging 3.8 ± 0.6 nmol g-1 wet weight in
rainbow trout (Figure 2-3A) and 38.8 ± 5.4 nmol g-1 wet weight, in white sucker
(Figure 2-4A). Interestingly, in the rainbow trout blood fractions, the concentration
of TFM within red blood cells averaged 14.1 ± 1.6 nmol ml-1, which was about 40
times more TFM than the plasma, which averaged 0.38 ± 0.1 nmol ml-1 (P < 0.01;
Figure 2-3A). Notably, more TFM had accumulated in the whole blood of white
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sucker compared to rainbow trout, in which the respective values were
approximately 50.0 ± 5.6 nmol ml-1, and 4.9 ± 0.5 nmol ml-1 (Figures 2-3A, 2-4A).
Like the parent compound, the relative amounts of TFM-glucuronide were
highest in the liver for rainbow trout and white sucker, followed by whole blood and
then muscle (Figures 2-3B, 2-4B). In contrast, relative TFM sulfate levels in whole
blood were similar to those measured in liver for both species (Figures 2-2C, 2-3C).
Interestingly, the relative amounts of TFM-glucuronide in rainbow trout were much
higher in the plasma compared to red blood cells, opposite to the trend observed for
parent TFM (Figure 2-3B), and TFM-sulfate was more or less evenly distributed
between the plasma and red blood cells in rainbow trout (Figure 2-3C).
Series 3 - Dose-dependent Changes in the Distribution of TFM and its Metabolites
in Rainbow Trout Tissues
The nominal TFM concentrations of 5, 10, 15, 20, 25 and 30 mg l-1 in the
rainbow trout range finder were measured as 5.45, 11.34, 16.47, 21.89, 25.33 and
30.98 mg l-1, respectively. At the three lowest concentrations of water TFM, liver
TFM was more or less stable, fluctuating around 180 nmol g-1 wet weight. An
abrupt, 70 % increase in liver TFM was then observed when the fish were exposed
to 21.9 mg L-1 TFM, which began to cause partial mortality during the experiment,
but did not result in a difference in liver TFM between fish that survived and fish
that died. Tissue TFM then increased a further 70 % when it peaked at external TFM
concentration of 25.3 mg L-1 (Figure 2-5A). White muscle exhibited a more gradual
accumulation of TFM, which increased in a step-wise fashion before stabilizing near
17 nmol g-1 wet weight in fish that survived the higher exposure concentrations
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(Figure 2-5B). Concentrations of TFM in muscle of fish that did not survive were
significantly higher (P < 0.01), reaching about 28 nmol g-1 and plateauing near this
concentration at the three highest exposure concentrations (Figure 2-5B). The
accumulation of TFM in the whole blood matched the trend seen in the white muscle
of fish exposed to TFM at the three lowest concentrations, during which the ratio of
muscle:blood TFM was approximately 1:1. However, the increase from 16.5 to 21.8
mg L-1 TFM resulted in an abrupt 4-fold increase in whole blood TFM concentration
of fish that did not survive, at which point it more or less stabilized between 70 and
90 nmol ml-1, while blood concentrations of fish that survived 12 h remained
unchanged from levels, 25-30 nmol ml-1, found at water concentrations of 21.9 and
25.3 mg l-1 (Figure 2-5C).
The relative amounts of metabolites in the tissues of rainbow trout exposed
to various TFM concentrations generally increased as exposure TFM increased,
resulting in highest relative amounts at the middle exposure concentrations
compared to the levels of parent TFM, which were greatest at the high exposure
concentrations. Differences in metabolites in the blood and tissues of fish that
survived and those that did not were transient and generally no different from each
other (Figures 2-6, 2-7).
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Discussion
Comparing the Toxicity of TFM to Two Non-Target Fish Species
The present study shows the 12h-h LC50 of rainbow trout in water with a pH
of 8.24 and an alkalinity of 231 mg l-1 CaCO3 to be 13.27 mg l-1, which more-or-less
matches predictions of the expected LC50s for brown trout under similar water
chemistries. The sensitivity of white suckers to TFM is still unclear, as some studies
have shown them to be slightly more tolerant to TFM (Marking and Olson, 1975),
but other suggest that they are slightly more sensitive to TFM, compared to rainbow
trout (Applegate and King, 1962; Boogaard et al., 2003). The white suckers were
exposed to a similar range of nominal TFM concentrations, and although this
experiment shows that white suckers are slightly more tolerant to TFM, as seen by
the higher 12-h LC50 14.99 mg l-1, compared to 13.27 mg l -1 for the trout, the
difference in sensitivity between rainbow trout and white sucker to TFM could be
even greater due to the slightly lower pH measured during the white sucker
experiment. Lower water pH is known to increase the toxicity of TFM due to the
increased uptake of the more lipophilic, un-ionized form of TFM (Applegate et al.,
1961; Hunn and Allen, 1974; Howell et al., 1980; McDonald and Kolar, 2007; Hlina et
al., 2017). Based on these observations, it seems likely that if the experiments were
run at the same pH, as for rainbow trout, the TFM tolerance of white sucker could be
even higher.
It should also be noted that a difference in temperature was measured
between the two experiments. The rainbow trout were exposed to TFM at an
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average temperature of 17.3˚C in the summer, and the white sucker experiment
averaged a temperature of 11.7˚C in the winter. TFM is mainly taken up by passive
diffusion across the gills, but warmer temperatures can lead to an increase in
metabolic rate, leading to increased ventilation rates (Hunn and Allen, 1974; Moffit
and Crawshaw, 1983), leading to increased rates of TFM uptake via the gills, and
greater toxicity (Scholenfield et al., 2008; Patra et al., 2009; Hooper et al., 2013). It
has been shown that warmer temperatures cause an increase in the rates of TFM
uptake by sea lamprey (Hlina. 2015). However, Howe et al., (1994) determined that
the toxicity of nitrophenols decrease as temperatures increase from 7 to 17˚C. In
larval lampreys, Muhametsafina (2018) also noted much greater survival during
TFM exposure in warmer (21°C) versus cooler water (5°C). Such observations could
be due to temperature dependent increases in metabolism and excretion of TFM,
which could ultimately lower toxicity as suggested for other toxicants (Noyes et al.,
2009). A study by Patra et al. (2015) supports this hypothesis, based on reductions
in phenol toxicity as temperature increased from 5 to 15˚C, but they also reported a
subsequent increase in phenol toxicity as temperatures continued to increase to
25˚C.
Distribution of TFM in the Tissues of Non-target Fishes Exposed to Their
Respective 9-h LC25
To determine how TFM and its metabolites are distributed in the tissues of
non-target fishes, rainbow trout and white sucker were exposed to their respective
9-h LC25. For both species, by far the greatest TFM concentration was found in the
liver, in which TFM was more than an order of magnitude grater than observed in
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the muscle and blood of rainbow trout, as shown previously by Lech and Statham,
(1975). In white sucker, the difference in TFM concentration was less pronounced,
but still 4-5-fold greater in liver compared to muscle and whole blood. This was
expected because the liver is the main site of detoxification of endogenous and
xenobiotic compounds, with past studies demonstrating that TFM preferentially
accumulates in the liver of non-target fishes (Lech, 1974; Lech and Statham, 1975;
Clark et al., 1991; Vue et al., 2002; Hubert et al., 2005). As TFM diffuses across the
gill epithelium into the blood of the fish, it enters circulation, from which it will
reach the liver via hepatic arteries. The hepatic arteries, along with the hepatic
portal vein, which delivers blood to the liver from the gastrointestinal tract, deliver
massive amounts of blood to the liver in most vertebrates, including fishes (McLean
and Ash, 1989; Satchell, 1971). This is one reason why TFM rapidly accumulates in
this organ, for subsequent biotransformation via Phase II metabolism (Lech and
Statham, 1975; Kane et al., 1993). Due to its additional roles in digestion and lipid
metabolism, the liver also has a relatively high lipid content which also aids in the
accumulation of lipophilic TFM.
The accumulation of TFM could be further augmented by the presence of
organic anion transporters (OATs) on the basolateral membrane of hepatocytes.
These OATs transport negatively charged organic compounds, such as TFM, into the
hepatocyte, where the compounds undergo biotransformation and subsequent
secretion into the biliary caniculus of the bile ducts, which lead to either the gall
bladder or the gastrointestinal tract, from which the more water soluble metabolite
is excreted to the environment (Bévalot et al., 2016). At physiological pH (7.2-7.8
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for a trout; Wilkie and Wood, 1995), the majority of TFM would be in its ionized,
phenolate form, making it an ideal candidate for anion transport into the
hepatocyte, where it would be trapped until cleared from the cell in glucuronide
and/or sulfate conjugate form.
While the concentration of TFM is the highest in the liver on a per gram wet
tissue basis, it should be noted that the muscle comprises about 55% of the total
weight of the rainbow trout compared to the liver at 1.3% and to the blood at 3.1%
of the total fish weight (Giblin and Massaro, 1972). In the the present study, the total
TFM stored in the whole body of rainbow trout was actually greatest in the white
muscle at a value of 2.07 nmol g-1 total fish weight compared to 0.84 nmol g-1 total
fish weight in the liver. Although TFM concentrates in the liver due to its high blood
flow and role in detoxification, the skeletal muscle serves as a large overall sink in
which TFM accumulates.
The much higher concentration of TFM found in the red blood cell fraction of
the blood of rainbow trout compared to the plasma could be explained partially by
the movement of TFM across cell membranes in its un-ionized (phenolic) form, as
well as the binding of TFM to cellular proteins in its ionized (phenolate) form. TFM
is a weak acid with a dissociation constant (pKa) of 6.07 (Applegate, 1961), meaning
that at physiological pH (7.2-7.8; Wilkie and Wood, 1995), more than 90% of the
TFM will exist in its ionized form, and the rest in its un-ionized form (Howell et al.,
1980; Bills et al., 2003; McDonald and Kolar, 2007). Due to the lipophilic nature of
un-ionized TFM, it is able to enter red blood cells by passive diffusion down its
concentration gradient. Once inside the red blood cell, 93% of the un-ionized TFM
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will naturally dissociate to its ionized (phenolate) form, which could possibly bind
to possibly bind to positively charged amino acid residues on hemoglobin proteins
inside the erythrocyte (Steck, 1974). This binding of TFM could, in turn, sustain the
inward directed concentration gradient of TFM between the red blood cells and
extracellular fluid (plasma), essentially creating a sink within the cells to promote
TFM uptake (Figure 2-8). If TFM binding to hemoglobin caused a conformational
change in the protein, it could affect its affinity for oxygen. Therefore, the effect of
TFM on the binding of oxygen to hemoglobin deserves future investigation. In the
muscle, TFM could be taken-up and sequestered in a similar manner, but it is less
clear why concentrations would be lower in the muscle than in the RBCs.
Although it is well established that TFM-glucuronide was a major metabolite
of TFM in non-target fishes (Lech and Costrini, 1972; Lech et al., 1973; Kane et al.,
1994), TFM-sulfate was recently been discovered to be another TFM metabolite
(Bussy et al., 2017b). With this new information, it now appears that when TFM
reaches the liver, it undergoes phase II biotransformation, in which it is conjugated
to TFM-glucuronide via uridine diphosphate glucuronsyltransferase (UDPGT; Lech
and Costrini, 1972; Lech et al., 1973; Kane et al., 1994) and to TFM-sulfate, most
likely via phenol sulfotransferase (PST; Bussy et al., 2017a). The present study
demonstrates for the first time, that both rainbow trout and white sucker
accumulate significant amounts of each metabolite, primarily in the liver. However,
the relative amounts of TFM-sulfate levels in whole blood were much higher than
for the glucuronide conjugate. It is not clear why TFM-sulfate was relatively higher
than TFM-glucuronide, but it may be related to differences in how the two
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metabolites are handled by the liver. Both TFM-glucuronide and TFM-sulfate are
highly hydrophilic, and are bi-directionally transported between the sinusoidal
blood of the liver and the basolateral membrane of hepatocytes and the biliary ducts
using organic transporting polypeptides and/or organic anion transporters (ZamekGliszczynski et al., 2006; Bévalot et al., 2016). These transporters are responsible for
delivering conjugated compounds to the bile ducts for excretion (Bévalot et al.,
2016), but also protect the liver from damage due to the accumulation of these and
other substances (Deeley et al., 2006). Differences in the affinities and capacities of
these transporters for sulfated vs glucuronidated compounds can influence the
concentrations of biotransformed substances excreted from the liver into the blood
(Deeley et al., 2006). Similar differences in the handling of TFM-glucuronide
compared to TFM-sulfate may explain the relative differences in the blood.
While TFM-sulfate seems to be evenly distributed between the different
blood fractions of rainbow trout, TFM-glucuronide exhibited an opposite pattern.
The relatively high amount of TFM-glucuronide found in the plasma compared to
the red blood cell pellet is likely related to its greater hydrophilicity due to its more
polar structure. As a result, the TFM-glucuronide tended to remain in the plasma
because it was unable to cross the plasma membrane of the red blood cell. This also
lends further support to the hypothesis that TFM accumulation by the red blood
cells and white muscle by passive diffusion, when its un-ionized, more lipophilic
form, before getting trapped in its ionized, less lipid permeable form.

38

Dose-dependent Changes in the Distribution of TFM and its Metabolites in
Rainbow Trout Tissues
The present study suggests that at sub-lethal exposure concentrations, relatively
stable steady state levels of TFM are maintained in the liver of rainbow trout.
Beyond these concentrations, the liver TFM spikes, suggesting that the livers
capacity to detoxify TFM is exceeded, leading to a spill over of TFM characterized by
increased TFM concentrations in the blood and white muscle and likely other tissues
such as the brain, ultimately causing death. Survival to TFM exposure is directly
related to detoxification capacity, as determined by a fish’s ability to metabolize
TFM via glucuronidation and sulfation (Lech and Statham, 1975; Clark et al., 1991;
Kane et al., 1993; Bussy et al., 2017b). Many studies have shown that the selective
toxicity of TFM to sea lamprey is due to their lower capacity to detoxify the
lampricide via glucuronidation, compared to other non-target fishes (Lech, 1974;
Lech and Statham, 1975; Kane et al., 1993). Lech and Statham (1975) reported the
higher ratio of free to conjugated TFM in sea lamprey compared to rainbow trout,
which indicates that biotransformation of TFM to hydrophilic metabolites is critical
for its elimination and subsequent survival during exposure to TFM. The present
study demonstrates that at sub-lethal exposure concentrations, biotransformation
of TFM by rainbow trout liver occurs at a rate high enough to prevent spillover into
blood and other tissues, resulting in subsequent toxicity. Further support for this
hypothesis is illustrated by the increases in relative levels of TFM-glucuronide and
TFM-sulfate in the liver at increasing, yet still sub-lethal exposure concentrations,
even as the parent TFM concentrations remain more or less stable. However, when
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fish were experiencing mortality at higher exposure concentrations, the levels of
conjugated metabolites plateaued and then decreased at the highest exposure
concentration. In other words, the capacity of the fish to detoxify TFM was
overwhelmed.
In the present study, the levels of TFM quantified in rainbow trout liver,
blood and white muscle were similar to earlier studies on the non-target effects of
TFM. Birceanu et al. (2014) measured a peak TFM concentration of about 15 nmol g1

wet tissue in the muscle of rainbow trout exposed to a concentration of 11 mg l-1

and Lech and Statham, (1975) observed a TFM concentration of about 25 nmol ml-1
in the blood of rainbow trout exposed to 8 mg l-1 TFM. The similar concentrations of
TFM in livers of fish that survived the treatments and fish that did not, combined
with the significant difference in TFM levels in the blood and muscle of the surviving
fish and those experiencing mortality, strongly suggests that when liver TFM
concentrations exceed a threshold of about 20-25 nmol g-1 wet weight, it could
cause death. Concentrations below these values make it less likely that TFM directly
caused death. Of course other exacerbating factors such as water temperature,
dissolved oxygen or the presence of other natural or anthropogenic stressors would
need to be considered when investigating a fish kill following lampricide
applications, and should be addressed in future studies. In cases where blood
samples are available, concentrations in excess of 60 nmol ml-1 would also be
indicative of death arising from TFM exposures. In many cases, however,
decomposition will make the collection of blood, and possibly liver, impractical, if
not impossible. In such instances, muscle should be collected because it decomposes
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at a much slower rate than liver or blood and provides a reliable measure of
postmortem TFM concentrations.
Relevance for non-target mortality investigations
It is important to note that non-target fishes typically will not be exposed to
concentrations of TFM as those encountered by the fish in this experiment because
TFM is applied in the field at 1.2-1.5 times the minimum lethal concentration (MLC)
of TFM to lamprey. The MLC is defined as the concentration of TFM required to
produce 99.9% mortality to larval sea lamprey during a 9-h exposure (Brege et al.
2003), and this value is typically much lower than 9-h LC25 of most non-target fishes,
including rainbow trout (Howell et al., 1980; Boogaard et al., 2003, McDonald and
Kolar, 2007). Nevertheless, these findings provide investigators of non-target fish
kills with important tools to investigate such incidents, particularly if TFM toxicity is
suspected.
The present data shows that, in the case of non-target fish kills, muscle can
provide very useful quantitative information that can be used to ascertain if TFM
might have contributed or caused death. If mortalities are relatively recent, the
present study suggests that blood can also be used to quantify TFM concentrations,
which in some cases would corroborate conclusions based on muscle TFM
measurements. Recent studies from our lab have also demonstrated that TFM
concentrations in liver rapidly decrease in the 24-72 h following death due to the
rapid decomposition of the fish (White, 2018). Muscle, however, is relatively robust
to decomposition over the same time frame and TFM concentrations do not
significantly change. Taken together, these findings suggest that the collection of
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white muscle should always be collected when TFM is suspected of causing nontarget mortality, because it provides stable, quantifiable and interpretable
postmortem data.
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Table 2-1. Species and tissue specific extraction efficiency and corresponding
extraction coefficients. All tissue TFM and metabolite measurements were
multiplied by their respective extraction coefficient to correct for efficiency of the
solid phase extraction method, which was measured by dividing TFM measurements
from spiked tissues that went through the extraction process by TFM measurements
from spiked tissues that did not go through the extraction process.

Species

Tissue
Muscle

Extraction
Efficiency (%)
86.3

Extraction
Coefficient
1.137

Rainbow Trout
Rainbow Trout

Liver

77.5

1.225

Rainbow Trout

Whole Blood

24.6

1.754

Rainbow Trout

Plasma

2.0

1.98

Rainbow Trout

RBC Pellet

46.2

1.538

White Sucker

Muscle

37.1

1.629

White Sucker

Liver

67.8

1.322

White Sucker

Whole Blood

3.2

1.968
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Figure 2-1. QTOF-MS ion chromatograms of TFM and its metabolites in
rainbow trout. A) Muscle and B) Liver samples with total ion count peaks
representing measurements of TFM-glucuronide (382 m/z; blue) with its
breakdown products at acquisition time 1.326 min, TFM-sulfate (285 m/z; black,
not seen) with its breakdown products at acquisition time 1.641 min, and TFM (206
m/z; green) with its breakdown breakdown product (176 m/z; pink) at acquisition
time 2.058 min.
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Figure 2-2. Dose response curves in rainbow trout and white Sucker exposed
to TFM. Percent mortality of (A) rainbow trout (Oncorhynchus mykiss; N = 18) and
(B) white sucker (Catostomus commersonii; N = 5) exposed to various
concentrations of 3-trifluoromethyl-4-nitrophenol (TFM) or held under control
conditions (no TFM exposure) for 12 h. Lethal concentrations (LC) and acute toxicity
was determined by probit analysis. Exposure concentrations were measured as
4.71, 7.83, 10.95, 13.51, 18.21 and 30.02 mg l-1 TFM for rainbow trout and 2.17,
4.27, 7.34, 12.25, 18.34, 19.59, 22.38, 23.91 and 32.67 mg l-1 TFM for white sucker.
TFM concentration is expressed on a Log10 scale against a percent mortality
expressed as a percentage of 1.
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Figure 2-3. Distribution of TFM and its metabolites in rainbow trout blood and
tissues. (A) Quantification of 3-trifluoromethyl-4-nitrophenol (TFM) in different
tissues and blood fractions of rainbow trout (Oncorhynchus mykiss) exposed to their
pre-determined 9 h LC25 (12.9 mg l-1 TFM). Relative signal area of (B) TFMglucuronide conjugate and (C) TFM-sulfate conjugate in the same tissues of rainbow
trout. The metabolite signal area of tissue samples were normalized by expressing
their values as a percentage of the value obtained from the liver samples. All data
are expressed as the mean + 1 SEM (N = 10). Bars sharing the same letter are not
significantly different from one another (P < 0.05).

48

(A)

(B)

(C)

49

Figure 2-4. Distribution of TFM and its metabolites in white sucker blood
and tissues. (A) Quantification of 3-trifluoromethyl-4-nitrophenol (TFM) in
blood and tissues of white sucker (Catostomus commersonii) exposed to their
pre-determined 9 h LC25 (18.3 mg l-1 TFM). Relative signal area of (B) TFMglucuronide conjugate and (C) TFM-sulfate conjugate in the same tissues of
white sucker. The metabolite signal area of tissue samples were normalized by
expressing their values as a percentage of the value obtained from the liver
samples. All data are expressed as the mean + 1 SEM (N = 10). Bars sharing the
same letter are not significantly different from one another (P < 0.05).
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Figure 2-5. Dose dependent changes in the distribution of TFM in rainbow
trout tissues. Quantification of 3-trifluoromethyl-4-nitrophenol (TFM) in (A)
liver (B) muscle and (C) blood of rainbow trout (Oncorhynchus mykiss) exposed
to various TFM concentrations (measured 5.45, 11.34, 16.47, 21.89, 25.33 and
30.98 mg l-1 TFM). All data are expressed as the mean + 1 SEM (See appendix C
for sample sizes). Different lower case letters denotes significant differences
between “surviving” groups of fish at the different concentrations. Different
upper case letters denotes significant differences between fish experiencing
mortalities at each concentration. Asterisks denote significant difference
between fish surviving TFM exposure and those experiencing mortality at the
same concentration (P < 0.05).
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Figure 2-6. Dose dependent changes in the distribution of TFM-glucuronide
in rainbow trout tissues. Relative amounts of TFM-glucuronide in (A) liver (B)
muscle and (C) blood of rainbow trout (Oncorhynchus mykiss) exposed to various
TFM concentrations (measured 5.45, 11.34, 16.47, 21.89, 25.33 and 30.98 mg l-1
TFM). The metabolite signal areas of tissue samples at all concentrations were
normalized by expressing their values as a percentage of the greatest average
value obtained from the liver samples. All data are expressed as the mean + 1
SEM (See Appendix C for sample sizes). Different lower case letters denotes
significant differences between “surviving” groups of fish at the different
concentrations. Different upper case letters denotes significant differences
between fish experiencing mortalities at each concentration. Asterisks denote
significant difference between fish surviving TFM exposure and those
experiencing mortality at the same concentration (P < 0.05).
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Figure 2-7. Dose Dependent changes in the distribution of TFM-sulfate in
rainbow trout tissues. Quantification of TFM-sulfate in (A) liver (B) muscle and
(C) blood of rainbow trout (Oncorhynchus mykiss) exposed to various TFM
concentrations (measured 5.45, 11.34, 16.47, 21.89, 25.33 and 30.98 mg l-1
TFM). The metabolite signal areas of tissue samples at all concentrations were
normalized by expressing their values as a percentage of the greatest average
value obtained from the liver samples. All data are expressed as the mean + 1
SEM (See Appendix C for sample sizes). Different lower case letters denotes
significant differences between “surviving” groups of fish at the different
concentrations. Different upper case letters denotes significant differences
between fish experiencing mortalities at each concentration. Asterisks denote
significant difference between fish surviving TFM exposure and those
experiencing mortality at the same concentration (P < 0.05).
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Figure 2-8. Proposed model of TFM-protein binding in erythrocytes. The unionized form of TFM enters red blood cells by passive diffusion down its
concentration gradient. Once inside the red blood cell, 95% of the un-ionized TFM
will naturally dissociate to its un-ionized form, which then binds to positively
charged proteins inside the erythrocyte. The binding of TFM to a protein, in turn,
increases the concentration gradient of TFM between the red blood cells and
extracellular fluid (plasma), creating a sink within the cells causing more TFM to be
taken up.
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Chapter 3:
Postmortem Handling and Storage of Non-Target Fish Tissues After Exposure
to TFM

60

Introduction
The piscicide 3-trifluoromethyl-4-nitrophenol (TFM) has been key to the
successful control of invasive sea lamprey (Petromyzon marinus) populations in
the Great Lakes for over 60 years (Great Lakes Fishery Commission, 2011). Its
application to streams and tributaries around the Great Lakes has lead to the
resurgence of commercial, recreational and culturally significant fisheries
(Lawrie, 1970; Christie, 1974; Christie and Goddard, 2003; Zimmerman and
Krueger, 2009; Great Lakes Fishery Commission, 2017). TFM is selectively toxic
to larval sea lampreys because non-target fishes are able to detoxify it via
glucuronidation and sulfation to a greater extent than sea lamprey (Lech, 1974;
Lech and Statham, 1975; Kane et al., 1994; Bussy et al., 2017b).
Although concentrations of TFM applied to streams are typically sublethal for non-target fishes, mortality can result from accidental over-application
and/or decreases in stream pH (McDonald and Kolar, 2007). As a weak acid,
with a pKa of 6.07, the proportion of TFM in its more diffusible un-ionized form
increases as pH decreases, leading to greater TFM uptake at low compared to
higher water pH (Hunn and Allen, 1974; Hlina et al., 2017. Drops in water pH can
result from precipitation, agricultural runoff, or photosynthesis and aerobic
respiration by aquatic vegetation and algae (Wetzel, 1983; Poudel et al., 2013).
Non-target fish kills can also result from natural causes such as extreme
temperatures, oxygen depletion, disease, or xenobiotics (Meyer and Barclay,
1990).
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In instances where there is uncertainty about whether or not lampricides
contributed to fish kills, it is important to reliably ascertain the amount of
lampricide that has accumulated in the fishes, and whether or not the
measurements are indicative of toxic exposure concentrations. In the previous
chapter, threshold concentrations of TFM in the liver, muscle and blood were
established that could cause death in non-target fishes. However, uncertainty
about the reliability of such measurements could undermine interpretations of
postmortem liver, muscle or blood TFM concentrations. There is currently a lack
of information regarding how to best store and preserve fish tissues for the
quantification of TFM, not to mention, the identification of its metabolites TFMglucuronide and TFM-sulfate during investigations of non-target fish kills.
In forensic toxicology, the pre-analytic sampling and storage phase is a
source of great variation and can drastically affect the reliability of analyte
measurements in tissue samples (Skopp, 2004). Poor sample quality due to
inadequate sampling, handling and/or storage can potentially compromise the
accuracy and confidence in measurements of postmortem TFM and/or
metabolites, undermining the effectiveness of non-target mortality
investigations.
The purpose of the current study was to determine the effects that
variables such as tissue type, storage temperature, storage length and the use of
preservatives have on stability of TFM and its metabolites in the blood and
tissues of two non-target fishes, rainbow trout (Oncorhynchus mykiss) and white
sucker (Catostomus commersonii). Accordingly, after exposure to TFM, blood,

62

liver and muscle were collected and either immediately snap-frozen in liquid N2
and stored at -80˚C, or left on ice or at room temperature for a period of one
hour before freezing and storage at -80˚C until measurement of TFM and the
characterization of TFM metabolites. The effects of longer-term storage
conditions on TFM stability were then investigated by measuring TFM and its
metabolites in the blood and tissues after storing the samples for a one-week
period at -80˚C, freezing at -20˚C, refrigeration at 4˚C or storage at room
temperature. The effectiveness of storing muscle and liver in sodium fluoride
preservative was also determined as well as the utility of collecting and storing
whole blood in vacutainers containing different additives including the
anticoagulants lithium heparin, sodium citrate and Na2 EDTA, and the
preservative sodium fluoride (NaF).
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Material and Methods
Experimental Animals and Holding
Rainbow trout were purchased from Rainbow Springs Trout Hatchery
(Thamesford, Ontario) and white suckers were captured by seine netting from
Canagagigue Creek, Elmira, Ontario. Prior to importing the white suckers into
Laurier’s fish holding facilities, they were treated for ectoparasites in a formalin
bath (0.75% formalin; SOP I23 - Wilfrid Laurier Animal Care Committee). Both
the trout and white sucker were held in separate 800 L holding tanks in Wilfrid
Laurier’s Centre for Cold Regions and Water Science, each tank receiving a
mixture of reverse osmosis water and de-chlorinated, City of Waterloo tap water
(pH ~ 8.0, alkalinity ~150 mg l-1 as CaCO3, temperature ~15˚C) at a flow rate of
5-10 L min-1. The tanks holding rainbow trout were supplied with water from a
~2000 L recirculating system, equipped with mechanical and UV filtration. The
water supplied to the white suckers drained directly to waste to prevent mixing
of water with that supplying other fish being held in the facility. Rainbow trout
were fed with EWOS 3mm floating pellets and white suckers were fed a mixture
of bloodworms and EWOS #1 micro crumble feed 3 times per week to satiation.
Fish were held for at least 2 weeks but food was withheld for approximately 72 h
before commencing experiments to prevent fouling of TFM exposure containers
and build-ups of ammonia in the water. Both groups of fish were held under a 12
h light and 12 h dark photoperiod. All fish husbandry and experiments were
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approved by the Wilfrid Laurier University Animal Care Committee and followed
guidelines of the Canadian Council of Animal Care (CCAC).
Experimental Protocol
Series 1- Effects of One-Hour Storage Methods on the Stability of TFM
The goal of these experiments was to ascertain how the stability of TFM
and its metabolites in the blood, muscle and liver of rainbow trout (N = 9, 293.1
± 13.6 g, 28.2 ± 0.4 cm) and white sucker (N = 9, 85.9 ± 7.6 g, 18.8 ± 0.5 cm) was
affected by the method of sample preservation following TFM exposure.
Accordingly, fish were exposed for 6 h to their respective 9-h LC25 of TFM, which
was determined in Chapter 2. The goal was to expose the fish to TFM, with
minimal mortality over the 6 h exposure period and to achieve more-or-less
uniform TFM accumulation within each species of fish
The experimental setup was identical for both species, with each
acclimated overnight to darkened, individual 4 L exposure chambers contained
within a 200 L flow-through system continuously receiving dechlorinated, city of
Waterloo tap water at a flow rate of 0.5 liters per minute. Water chemistry was
more or less similar between the two experiments, but temperature varied
between the experiments (rainbow trout: water pH = 8.0 ± 0.01, T = 16.0 ±
0.07˚C, alkalinity = 255 mg l-1 as CaCO3, DO > 90%; white sucker: water pH = 8.1
± 0.03, T = 10.4 ± 0.02˚C, alkalinity = 238 mg l-1 as CaCO3, DO > 90%). Prior to the
addition of TFM, incoming water flow to the system was shut off to yield a closed
re-circulating system in which a submersible pump was used to pump water
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from a lower reservoir (~70 L) to a head tank (~ 70 L), from which water was
drained into the individual chambers of the fish. Based on the total volume of the
system, sufficient field formulation TFM (35% active ingredient dissolved in
isopropanol; Clariant SFC GMBH WERK, Griesheim, Germany; provided courtesy
of Fisheries and Oceans Canada) was added to achieve the desired TFM exposure
concentration. After a 20 minute mixing period, TFM concentrations were
verified spectrophotometrically using a NovaSpec II spectrophotometer
(Pharmacia Biotech, Cambridge, England, UK) at a wavelength of 395 nm
following Standard Operating Procedures of the Department of Fisheries and
Oceans, Sea Lamprey Control Centre, Sault Ste. Marie, Ontario (IOP: 012.4). After
6 h of TFM exposure, all fish were euthanized with an overdose of tricaine
methanesulfonate (MS222; 0.5 g l-1, buffered with 1.0 g l-1 NaHCO3) before
collection of blood, liver and muscle. To determine the effects of different storage
temperatures on the stability of TFM and its metabolites, whole blood, muscle
and liver from each fish were split into three sub-samples. The first sub-sample
was snap-frozen in liquid N2, the second was placed into a small tin-foil pouch
and placed on ice, and the third was placed into a tin-foil pouch and kept at room
temperature (measured 18.1˚C). After one hour all samples were stored at -80˚C
until processed for quantification of TFM, and characterization of TFMglucuronide and TFM-sulfate.
Series 2 – Effects of One-Week Storage Methods on TFM Stability
The goal of these experiments was to ascertain how storage under
different conditions for 1 week affected the stability of TFM and its metabolites
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in the blood, muscle and liver of rainbow trout (N = 8, 373.7 ± 20.1 g, 28.2 ± 1.57
cm) and white sucker (N = 9, 123.1 ± 9.5 g, 21.2 ± 0.55 cm) following 6 h of
exposure to TFM.
The TFM exposure protocol was identical to that described above (Series
1), with more or less the same water chemistry and temperature (rainbow trout:
water pH = 8.0 ± 0.03, T = 14.1 ± 0.01˚C, alkalinity = 238 mg l-1 as CaCO3, DO >
90%; white sucker: water pH = 7.8 ± 0.01, T = 12.9 ± 0.01˚C, alkalinity = 272 mg
l-1 as CaCO3, DO > 90%). As described in Series 1, after the incoming water flow
to the system was shut off to yield a closed re-circulating system, sufficient TFM
was added to achieve the desired TFM exposure concentration. After the 6 h
exposure period, the fish were euthanized as described earlier (Series 1),
followed by the collection of blood, liver and muscle. The samples of muscle and
liver that were collected from each rainbow trout were separated into 6 subsamples, while whole blood was sub-divided into 7 sub-samples each. The subsamples of muscle and liver (1-3g) were either snap-frozen in liquid N2, or
placed into a 15 mL polypropylene centrifuge tube and stored under the
following conditions for one week: -20˚C, 4˚C while submerged in 5 mL sodium
fluoride solution (+NaF), 4˚C without NaF (-NaF), room temperature (measured
20.2˚C) plus NaF, or room temperature (20.2˚C) minus NaF. Sodium fluoride
solution (1%), which is often used to help preserve forensic blood samples
(Skopp, 2004), was prepared using 1g of 99% pure NaF (Bioshop, Burlington,
Canada) added to 100mL of deionized water. Rainbow trout blood was either
snap-frozen in liquid N2, kept at -20˚C, 4˚C, or room temperature for a period of
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one week. The three remaining aliquots of rainbow trout blood were separated
into one of three different, colour-coded vacutainer blood collection tubes
(green, blue, grey; BD Vacutainer, Franklin Lakes, NJ, U.S.A.), and stored at 4˚C
for one week. The three types of containers contained (i) lithium heparin (green
caps), (ii) 0.109 M sodium citrate (blue caps) and (iii) NaF and Na2
ethylenediaminetetraacetic acid (EDTA; grey caps). White sucker muscle and
liver samples were sub-divided into 4 sub-samples each and either snap-frozen
in liquid N2, or stored at -20˚C, 4˚C or room temperature (20.2˚C) for a period of
one week. White sucker blood was sub-divided into four sub-samples each and
either snap-frozen in liquid N2 or separated into one of the three different
vacutainers and stored at 4˚C. After one week all trout and white sucker samples
were stored at -80˚C until processed for the quantification of TFM, and
characterization of TFM-glucuronide and TFM-sulfate at the Upper Midwest
Environmental Sciences Center (UMESC), U.S. Geological Survey, La Crosse,
Wisconsin, U.S.A.
Analytical Methods
Water TFM Measurements
Water TFM concentrations were measured spectrophotometrically using
either a 96-well microplate spectrophotometer (Epoch 2, Biotek Instruments,
USA) or a standard spectrophotometer (NovaSpec II), using 1.5 mL polystyrene
cuvettes. Unknown absorbances were measured at wavelength of 395 nm
against precision standards as described above.
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Quantitation of TFM and Characterization of TFM-metabolites in Liver, Muscle and
Blood
All blood and tissue samples were analyzed at UMESC, following the
protocol described in Chapter 2 (refer to Chapter 2 for details). Briefly, solid
phase extraction was performed on aliquots liver, muscle or blood using
acetonitrile containing 1% formic acid to extract TFM and TFM-metabolites. The
samples were homogenized and filtered using Phree phospholipid removal 96well plates (Phenomenex, Torrance, California, USA). The extracted sample was
then immediately injected into the reversed phase liquid chromatography
column (Phenomenex, Kinetex 1.7 µm Evo C18) interfaced with a quadrupole
time of flight mass spectrometry system (Agilent Technologies, 1290 Infinity II
LC and 6530 Accutate-Mass Q-TOF LC/MS system) for quantification of TFM and
its metabolites. Unused samples were frozen at -80˚C for later analysis.
In the present study, an LC mobile phase was used to separate TFM and
its metabolites through the liquid chromatography column. The eluent was then
pumped into the mass spectrometer source and accelerated through a vacuum
by an electrical field for analysis based on the mass to charge ratio (m/z) of the
ion fragment (Pitt, 2009). The ion counting detector measures the signal from
the ions and a chromatogram is produced with peak areas relating to the
intensity of signal from the ions, and thus the amount of ions in the sample
(Guilhaus, 1995). By comparing the relative signal size, the m/z ratio vs time of
flight against known TFM standards, the concentrations of parent compounds
were quantified. Due to the lack of standards for TFM metabolites TFM-
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glucuronide and TFM-sulfate, a standard curves could not be generated for these
compounds, making it impossible to report metabolite concentrations; therefore
all measurements of metabolites were reported in relative peak areas as
described by Bussy et al. (2017b).
Calculations and Statistical Analysis
Concentrations of TFM in tissues were determined by applying peak area
counts of the sample to the standard curve equation produced by measuring the
peak areas from standards of known concentration. A dilution factor taking into
account the volume of the extraction solution and homogenized tissue was
applied to the calculated concentration of the sample in ng ml-1. The resulting
concentration in ng g-1 was then converted into nmol g-1 TFM by dividing by the
molecular weight of TFM (207.11 g mol-1). Dilution factors were also applied to
the peak areas of the metabolites TFM-glucuronide and TFM-sulfate. The
extraction efficiency of TFM was calculated in different tissue matrices by
spiking the different TFM-free tissues with a known amount of TFM (spike
tissue) and performing the extraction as described above. Another sample was
measured that had the same spike solution of know concentration but without
the tissue (spike null). Extraction efficiency was then calculated using the
equation below:
Extraction Efficiency (%) = Spike tissue (ng/g) X 100 %
Spike null (ng/g)

(1)

A tissue specific extraction coefficient (EC; Table 2-1) was then applied to
the raw TFM concentration measured in each sample in ng ml-1, followed by the
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dilution factor (DF) then divided by the molecular weight of TFM to yield the
true concentration of TFM in the tissue in nmol g-1 for muscle and liver or nmol
ml-1 for blood via the following formula:
Tissue [TFM] = Sample [TFM] X EC X DF
207.11

(2)

To determine if submersion in sodium fluoride had any effect on tissue
water, rainbow trout muscle and liver was dried to a constant mass at 60°C
using a laboratory oven (Precision Scientific, Chicago, IL, U.S.A.). The
corresponding percent water content was then calculated using the formula
below:
% Tissue Water = (Wet mass – Dry Mass) X 100 %
Wet Mass

(3)

Submersion of muscle and liver into sodium fluoride preservative
increased the water content of each by about 9-10% in muscle and about 1012% in liver (Table 3-1). Storage at -20˚C, 4˚C or at room temperature, in the
absence of NaF, had no significant effect on tissue water content
Signal area measurements of TFM metabolites in the tissues of fish
exposed to their 9-h LC25 were normalized to the signal area in snap-frozen
samples and represented as a percentage.
Concentrations of TFM in tissues were analyzed using a one-way analyses
of variance (ANOVA) followed by a Tukey Honest Significant Difference post-hoc
test when data were homoscedastic and normally distributed. If these
assumptions were not met (even after transformations; inverse, square root,
Log10), a Kruskal-Wallis rank sum test was performed followed by a Dunn’s test
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of multiple comparisons was used. Interactive effects of sodium fluoride
preservative on the concentrations of TFM in liver and muscle kept 4˚C and room
temperature for one week were analyzed using a two-way ANOVA. The level of
significance was set at a P value ≤ 0.05. Statistical analysis and figures were
produced using R version 3.4.2, RStudio version 1.1.383 (RStudio, 2016), and
‘ggplot2’ (Wickham, 2016). All data are presented as the mean ± 1 standard
error of the mean (SEM).
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Results
Series 1- Effects of One-Hour Storage Methods on the Stability of TFM
Following exposure to respective TFM concentrations of 12.9 ± 0.03 and
17.9 ± 0.18 mg l-1 TFM (~ the respective 9h LC25) for 6 h, the greatest TFM
concentration was found in the liver for both rainbow trout and white sucker,
averaging 560 ± 53 and 182 ± 8 nmol g-1 wet weight, respectively (Figures 3-1A,
3-2A). After an hour on ice, TFM concentrations in rainbow trout liver dropped
significantly to 357 ± 91 nmol g-1 wet weight (P < 0.04), while 1 h at room
temperature resulted in an increase in TFM to 720 ± 134 nmol g-1 wet weight,
although this difference was not significantly different from snap-frozen levels
due to the high inter-sample variation (P = 0.76; Figure 3-1A). TFM in white
sucker liver was largely unaffected by storage temperature for a period of one
hour, remaining just below 200 nmol g-1 wet weight (Figure 3-2A).
The concentrations of TFM in snap-frozen rainbow trout muscle was
approximately 8.2 ± 0.8 nmol g-1 wet weight and remained stable after an hour
on ice and at room temperature (Figure 3-1A). The TFM in snap-frozen white
sucker muscle was 37.2 ± 2.0 nmol g-1 wet weight, and not significantly different
from the concentrations measured in muscle kept on ice and at room
temperature were which averaged 41.5 ± 3.3 and 26.7 ± 4.3 nmol g-1 wet weight,
respectively (Figure 3-2A).
Blood from rainbow trout kept on ice or at room temperature for an hour
showed no changes in TFM concentration from levels found in snap-frozen blood
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at 16.1 ± 1.6 nmol ml-1 (Figure 3-1A). White sucker blood also showed minimal
differences in TFM concentrations as samples held on ice or at room
temperature for one hour were not significantly different from snap-frozen
samples at 43.7 ± 2.3 nmol ml-1, although there was a slight decrease to 34.6 ±
3.7 nmol ml-1 TFM in samples kept on ice (P = 0.15), as well as a slight increase to
50.7 ± 3.6 nmol ml-1 TFM in samples kept at room temperature (P = 0.31; Figure
3-2A).
The relative amounts of TFM-glucuronide in rainbow trout liver kept on
ice for one hour were approximately 69 % greater than that found in snapfrozen livers, while samples kept at room temperature contained almost no
TFM-glucuronide (7 %) compared to that measured in snap-frozen samples
(Figure 3-1B). The relative amounts of TFM sulfate in trout liver were unchanged
following one-hour storage on ice or at room temperature (Figure 3-1C). The
relative amount of TFM-glucuronide in trout muscle was reduced by about 25 %
after one-hour on ice or at room temperature (Figure 3-1B). The levels of TFMsulfate in muscle kept on ice and at room temperature declined by about a third
compared to snap-frozen muscle (Figures 3-1C). This same trend was observed
for TFM-glucuronide in trout blood samples, while TFM-sulfate in the same
blood samples was not affected by storage temperature for a period of one hour
(Figures 3-1B, C).
The relative amounts of TFM-glucuronide in white sucker livers kept on
ice for one hour dropped about 50 % compared to levels in snap-frozen livers,
declining further after being kept at room temperature for an hour, to levels that
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were only 12 % of those observed in snap-frozen livers (Figure 3-2B). A similar,
yet slightly less pronounced trend occurred for TFM-sulfate in white sucker
livers as levels in samples kept on ice dropped by about 40 % and samples kept
at room temperature dropped by about 60 % of those found in snap-frozen
livers (Figure 3-2C). Although TFM-glucuronide in sucker muscle kept on ice was
similar to samples that were snap-frozen, there was a loss of about 50 % after
keeping the muscle at room temperature for an hour (Figure 3-2B). Levels of
both TFM-glucuronide and TFM-sulfate in white sucker blood were unaffected
by storage on ice or at room temperature for one a period of one hour (Figures
3-2B, C).
Series 2 – Effects of One-Week Storage Methods on the Stability of TFM
Parent TFM
Concentrations of TFM found in rainbow trout liver after a week of
storage at -20˚C did not appear to deviate significantly from levels found in livers
snap-frozen in liquid N2 (P = 0.36; Figure 3-3A). Conversely, the concentrations
of TFM in all other liver samples held at 4˚C and room temperature, plus or
minus NaF, underwent greater than 90 % reductions in TFM (P < 0.012; Figure
3-3A).
Concentrations of TFM in trout muscle were again more stable than in the
liver, ranging from approximately 6-9 nmol g-1 wet weight in samples stored at 20˚C and at 4˚C in both the presence and absence of NaF, compared to the levels
measured in snap-frozen muscle (Figure 3-3A). Storage at room temperature
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however, saw TFM significantly decrease to lower levels of 3.9 ± 2.4 and 0.83 ±
0.68 nmol g-1 wet weight for with and without sodium fluoride, respectively (P <
0.003; Figure 3-3A).
There was a slight interaction between storage temperature and NaF
preservative on liver samples kept at 4˚C and room temperature (P = 0.03).
However, NaF did not appear to affect concentrations of TFM in the muscle (P =
0.85)
In contrast to liver and white muscle, TFM concentrations in trout blood
significantly increased in an incremental fashion from 8.5 ± 1.5 nmol ml-1 in
snap-frozen samples to 11 ± 2.8, 23 ± 6.5, and finally 39.5 ± 5.7 nmol ml-1 after
storage at -20˚C, 4˚C and room temperature for a period of one week (Figure 33A).
Keeping samples of white sucker liver at -20˚C for one week did not affect
the concentration of TFM (173 ± 13.6 nmol g-1 wet weight), compared to snapfrozen samples (169 ± 11.7 nmol g-1 wet weight; Figure 3-4A). In contrast,
storage of the livers at 4˚C and at room temperature resulted in significant
decreases in TFM concentrations of 40 and 2% to 68.8 ± 18.7 nmol g-1 wet
weight (P = 0.01) and 3.70 ± 2.0 nmol g-1 wet weight (P < 0.01), respectively
(Figure 3-4A). The concentration of TFM in white sucker muscle was unchanged
from 25.6 ± 3.9 nmol g-1 wet weight after one week at -20˚C and 4˚C. After a week
at room temperature, however, TFM was below levels of detection (Figure 3-4A).
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TFM-Metabolites
After one week at -20˚C, the relative levels of TFM-glucuronide in
rainbow trout liver decreased by over 90% and TFM-sulfate by close to 60%
compared to levels found in snap-frozen samples (Figures 3-3B, C). All other
treatments resulted in TFM metabolite levels that were undetectable (Figures 33B, C). A similar trend was seen in rainbow trout muscle, other than at -20˚C, in
which the relative amount of TFM-glucuronide was unchanged (Figure 3-3B).
Keeping trout muscle at 4˚C with or without NaF preservative resulted in a
greater than 80% decrease in TFM-glucuronide after one week. At room
temperature however, TFM-glucuronide was undetectable after a week in both
the presence and absence of NaF (Figure 3-3B).
The relative amounts of TFM-sulfate in trout muscle samples kept at 20˚C and 4˚C without NaF at approximately 57 and 20% of that found in snapfrozen muscle samples, respectively, while all other treatments resulted in levels
that were undetectable (Figure 3-3C). The relative amount of TFM-glucuronide
in trout blood was about 38% greater after one week at -20˚C, whereas after a
week at 4˚C the levels decreased to about 39% of that found in snap-frozen blood
samples (Figure 3-3B). These results, however, were highly variable and not
significantly different from those found in snap-frozen samples, other than at
room temperature, in which relative levels of TFM-glucuronide were
undetectable. TFM-sulfate did not appear to change in trout blood in all
treatments, but values were highly variable. At room temperature, however,
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relative levels decreased by approximately 35% after one week, compared to
snap-frozen blood samples (Figure 3-3C).
Compared to snap-frozen samples, the relative amounts of both TFMglucuronide and TFM-sulfate in white sucker liver after a week at -20˚C
remained relatively constant, but were highly variable. However, after a week at
4˚C and at room temperature, both metabolites were undetectable (Figures 3-4B,
C). After a week at -20˚C and 4˚C, relative levels of TFM-glucuronide in white
sucker muscle were unchanged from levels found in snap-frozen samples, while
levels of TFM-sulfate decreased by 25 and 61%, respectively (Figures 3-4B, C).
Neither metabolite was measured in white sucker muscle after a week at room
temperature (Figures 3-4B, C).
Effects of Temperature, Anticoagulants, and Preservatives on Blood TFM Stability
After one week of storage at 4˚C in the green or grey vacutainers,
containing lithium heparin or NaF and Na2 EDTA, respectively, parent TFM in
rainbow trout blood significantly increased by more than 4-fold compared to the
snap-frozen blood samples (< 0.004; Figure 3-5A). Whereas storage of the blood
in the blue vacutainer containing sodium citrate at 4˚C, resulted in only a slight,
non-significant increase in TFM concentration (P = 0.36 Figure 3-5A). TFM in
white sucker blood also increased by more than 30 and 100%, respectively, after
storage in the green and grey vacutainers, relative to the snap-frozen samples
preserved in liquid N2 (Figure 3-6A). Conversely, after a week in the blue
vacutainer at 4˚C, TFM significantly decreased by more than 80% (P < 0.0004;
Figure 3-6A).
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The relative levels of TFM-glucuronide in rainbow trout blood
significantly decreased by greater than 50% after a week at 4˚C in the green
vacutainer, 80% after a week in the blue vacutainer, and over 95% after a week
in the grey vacutainer (Figure 3-5B), while levels of TFM-sulfate remained
relatively stable in all vacutainers. Although the relative levels of TFMglucuronide in the blood of white sucker-fish stored in the green vacutainer at
4˚C were similar to levels found in snap-frozen samples, there was almost no
TFM-glucuronide found in the blood stored in the blue or the grey vacutainers
for one week (Figure 3-6B), TFM-sulfate was not significantly different in blood
kept in the grey vacutainer for a week compared to snap-frozen blood samples,
while barely any metabolite was measured after a week in the blue vacutainer
(Figure 3-6C) . Levels of TFM-sulfate found after a week of storage in the green
vacutainer were about 40% of that found in snap-frozen blood samples (Figure
3-6C).
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Discussion
Distribution and Metabolism of TFM and its Metabolites
Quantification of TFM, along with the characterization of its metabolites, can
indicate if fish were exposed to TFM. In the present study, quantifiable amounts of
TFM were detected in the liver, muscle and blood of rainbow trout and white sucker
after just 6 h of exposure to their 9-h LC25 of TFM. Although, I was unable to
generate quantitative data on the two main TFM metabolites, TFM-glucuronide and
TFM-sulfate were detected by LC-MS analysis. The presence of these substances, as
confirmed by LC-MS analysis, would also provide strong evidence of prior TFMexposure in non-target fishes in the field. The presence of TFM metabolites was
confirmed by the detection of ions with calculated mass to charge ratios specific to
those of TFM-glucuronide (382.0391) and TFM-sulfate (285.9633), which are based
on molecular weight. It is known that the metabolites break down in the source of
the mass spectrometer to produce an TFM molecule, therefore the metabolite ions
were further confirmed to be metabolites of TFM because of the detection of ions
with calculated a mass to charge ratio specific to that of TFM (206.0071) at the same
elution times as each of the metabolites (Figure 2-1).
The vast majority of TFM was measured in the liver of both rainbow trout
and white sucker. This was not unexpected because the vertebrate liver is well
supplied with blood, arising from both the hepatic veins, and the hepatic portal
system, which receives blood from the gastrointestinal tract (Olson, 2011; Bévalot et
al., 2015). The hepatocytes of liver are also equipped with organic anion
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transporters (OATs) and organic anion polypeptides (OATPs), which can be used to
transport xenobiotics, which could include ionized TFM into the cells, as well as its
metabolites (Deeley et al., 2006; Bevalot et al., 2016). Due to its weak acid
properties and pKa of ~ 6.07 (25°C; Hubert, 2003), the majority of TFM exists in its
ionized form at physiological pH (pH 7.2-7.8 in trout; Wilkie and Wood, 1995). This
likely explains the preferential accumulation of TFM and its metabolites in the liver
relative to the muscle and the blood. However, further work is required to
determine if and how OATs and OATPs function in these tissues in fishes. The
presence, let alone physiological relevance, of such transporters in the blood and
muscle are also unresolved in mammals, not to mention fishes.
Increases in TFM-glucuronide were observed in both rainbow trout and
white sucker liver, white muscle and blood following TFM exposure. As the main site
of detoxification in the body, the liver has high amounts of the enzyme uridine
diphosphate glucuronsyltransferase (UDPGT), which catalyzes the addition of
glucuronic acid to the TFM, resulting in a more polar molecule that can be excreted
by the animals (Lech et al., 1972; Lech, 1974; Clark et al., 1991; Kane et al., 1994).
Until recently, however, there was no evidence to suggest that fish accumulated
physiologically or toxicologically relevant levels of TFM-sulfate during TFM
exposure. The present study demonstrates, for the first time, that non-target
rainbow trout and white sucker produce physiological relevant amounts of TFMglucuronide, as well as TFM-sulfate, suggesting that the metabolism of TFM is more
complicated than previously thought. Bussy et al., (2018a) detected TFMglucuronide and TFM-sulfate in sea lampreys and teleosts including trout, bluegill
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(Lepomis macrochirus) and lake sturgeon using extracts (S9 fraction) of liver tissue.
In vivo experiments were limited to sea lamprey, however, in which it was shown
that TFM-glucuronide and TFM-sulfate were present at very low levels in lamprey
compared to the parent TFM. Notably, high amounts of an amino metabolite of the
parent TFM were detected in vivo in the lamprey, likely because insufficient TFM
was metabolized using glucuronidation and sulfation pathways (Bussy et al.,
2018b). However, they did not complete similar in vivo experiments on non-target
fishes. The present study builds on these findings by further demonstrating that the
greater tolerance of non-target fishes, in this case rainbow trout and white sucker,
to TFM results from their greater capacity to produce significantly relevant amounts
of not only TFM-glucuronide but also TFM-sulfate. The goal of future studies should
be to better define the quantitative importance of these metabolites in TFM
detoxification by non-target fishes and sea lampreys.
Tissue Collection and Handling During the Pre-analytic Phase
The investigation of fish kills can be complicated during the pre-analytic
phase by the decomposition of tissues for prolonged periods of time, improper
sample collection and preservation, and inadequate conditions during shipping and
storage. It is therefore critical that procedures be used to eliminate or minimize
confounding factors that could compromise sample integrity. This could be difficult
in practice if fish mortality takes place in remote locations where a lack of access to
resources or facilities could complicate sample collection, preservation and storage.
Indeed, this could be the situation in instances of non-target mortality that may
arise during or following lampricide applications. Here, I report that parent TFM is
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relatively stable if it is preserved within an hour and either snap frozen in liquid N2,
kept on ice, or ensuring that the tissue is kept at room temperature for 1 h or less,
before freezing or refrigerating the sample for longer-term storage.
It is well established that the best way to preserve blood and tissue samples
for the postmortem analysis of endogenous substances and metabolites, as well as
exogenous compounds including xenobiotics, drugs and pesticides is to freeze the
samples as fast as possible and keep them frozen until analysis (Wang et al., 1994;
Butzbach, 2010). Snap freezing in liquid N2 combined with storage at -80˚C will
protect the sample from enzymatic or microbial decomposition by slowing down or
stopping these processes while also keeping them viable upon thawing (Wang et al.,
1994; Lin et al., 2007). Failure to adequately preserve tissues, such as having to
store tissues at ambient temperatures due to a lack of refrigeration, ice or freezing
capacity can cause the breakdown of tissue structures and organelles. Autolysis and
edema begins minutes after the removal of the tissue, as blood flow and oxygen
supply is cut off and endogenous enzymes (e.g. lipases, proteases) continue to
function (Zhou and Byard, 2011). Without oxygen, ATP is temporarily produced via
anaerobic pathways producing lactate and acid, resulting in decreased intracellular
and extracellular pH, that can activate proteolytic enzymes released from
intracellular compartments such as lysosomes (Skoop, 2004; Yarema and Becker,
2005; Butzbach, 2010; Zhou and Byard, 2011). Further complications can arise if
ambient temperatures favour microbial growth and enzymatic activity, which can
further accelerate postmortem cellular and tissue degradation (Skoop, 2004;
Yarema and Becker, 2005, Zhou and Byard, 2011). It is therefore not only critical to
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select tissues that can be easily collected, preserved and stored, but to understand
how concentrations of the analytes of interest, in this case TFM and its metabolites,
respond to variations in sampling, preservation, handling and storage methods. As
the present study demonstrated, the liver, muscle and blood meet these criteria,
with limitations related to the method of preserving and handling of each tissue.
The present study demonstrates that TFM can be reliably measured in liver,
muscle and blood, and that the most effective means of preserving TFM
concentration is by snap-freezing the sample in liquid N2. However, preservation of
tissues on ice or even leaving them at room temperature (1 h) did not markedly
compromise sample integrity. The preservation of the liver on ice or at room
temperature for 1 hour only resulted in slight decreases in TFM concentration in the
rainbow trout, but not in white sucker in which tissues were more or less stable. In
both fishes, TFM was also relatively stable in both muscle and blood, suggesting that
these tissues are somewhat robust to different sampling procedures. Taken together
these findings suggest that reliable measurements of TFM can be collected from
liver, muscle or blood if liquid nitrogen (or other rapid deep-freeze method such as
dry ice) is not available. Putting the samples on ice helps to preserve TFM in
instances where liquid N2 is not available. Even if ice is unavailable, temporarily
leaving the samples in air (Capped) will only result in slight increases in variation of
TFM, so getting the samples collected and stored (e.g. -20°C or 4°C) as quickly as
possible, would likely yield samples of analytical value.
Although the relative amounts of TFM-glucuronide were more or less stable
in tissues that were kept on ice, the metabolite was susceptible to degradation in the
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liver if the samples were kept at room temperature for 1 hour, after which only
traces of the metabolite remained. The loss of TFM-glucuronide may have been due
to hydrolysis of the metabolite by the enzyme β-glucuronidase, which is found in the
intestinal microbial community of mammals (Gadelle et al., 1985; Paigen, 1989). βglucuronidase is a hydrolytic enzyme commonly found in animal tissues including
liver, kidney, spleen, intestinal epithelium as well as gut bacteria that can hydrolyze
glucuronide conjugates to liberate unconjugated, parent compounds (Paigen, 1989;
Lampe et al., 2002; Butzbach, 2010). While in vivo studies on β-glucuronidase
activity in fish are limited, especially in relation to TFM, Lech (1973) has used βglucuronidase in vitro to study the metabolism of TFM by rainbow trout. It is not
known if the microbial community of fishes contains similar microbial biota, but this
information should become available in the next few years as more is learned about
the gut microbiome of fishes (Tarnecki et al., 2017).
The relative amounts of TFM-sulfate on the other hand were relatively
constant in rainbow trout liver suggesting that little to no sulfatase-mediated
degradation of the metabolite took place within one hour on ice or at room
temperature in the liver or blood. Curiously, TFM-sulfate was less stable in muscle.
This is somewhat counterintuitive because the muscle would be less prone to
bacterial contamination than the liver or blood, due to its relative isolation from the
gut. Perhaps decreases in intramuscular pH associated with the lack of blood flow
promoted the hydrolysis of TFM-sulfate?
In contrast to the rainbow trout, there was no significant difference in parent
TFM concentrations after keeping the liver on ice or at room temperature for one
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hour. As in the trout, however, the concentrations of TFM were relatively stable in
the white muscle and blood.
A notable observation was that compared to rainbow trout, white sucker
accumulated 3-4 fold as much TFM in the muscle and blood. Although the relative
TFM exposure was the same for both species (9-h LC25), the white suckers were
exposed to a higher absolute concentration of TFM (17.9 mg l-1 vs. 12.9 mg l-1)
These findings suggest that the detoxification capacity of the trout liver is likely
greater than that of the white sucker. At first glance, this observation would appear
counterintuitive because TFM concentrations were 1.5-3.0 fold greater in the trout.
As pointed-out in Chapter 2, however, the accumulation of TFM in the blood and
white muscle was relatively stable as TFM exposure concentrations were increased,
before exceeding an “upper concentration” in the liver, at which point muscle and
blood concentrations began to increase or “spike”. This likely was the result of a
“spill-over” of TFM that occurred when the liver’s capacity to detoxify TFM was
exceeded, resulting in the accumulation of parent TFM by blood and muscle. Thus,
greater accumulation of TFM in the blood and white muscle of white sucker may
because the liver of this animal has a lower overall capacity to store and detoxify
TFM than in rainbow trout.
The higher liver TFM in the rainbow trout could also reflect higher rates of
TFM uptake by the trout compared to the white sucker. Indeed, the routine
metabolic rates of comparably sized trout are much higher than those of white
sucker (Beamish, 1964), which would be associated with greater oxygen demands
and rates of TFM uptake due to greater ventilation at the gill. Indeed, Tessier et al.,
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(2018) demonstrated that TFM uptake was closely correlated with routine rates of
oxygen consumption in larval sea lamprey. It would be very useful to conduct
similar experiments on non-target species to establish inter-species relationships
between TFM uptake and species-dependent metabolic rate.
Compared to rainbow trout exposed to their 9-h LC25 in Chapter 2, the fish in
this experiment were, on average, about 100 g larger. This may explain why there
was greater accumulation of TFM in the in the blood, muscle and liver of the larger
fish. This was somewhat un-expected because larger fish have a relatively lower
metabolic rate compared to smaller fish (Gillooly et al., 2001). Because smaller fish
have higher metabolic demands and therefore greater rates of O2 uptake, gill
ventilation and delivery of TFM to the fish would be expected to be higher, resulting
in a greater accumulation of the parent TFM in the blood and tissues of the smaller
fishes (Gillooly et al., 2001). In fact, Tessier et al. (2018) determined that relatively
smaller sea lamprey took up TFM at much higher rates compared to larger ones.
However, it should be kept in mind that sea lamprey have a low capacity to detoxify
TFM compared to trout. Perhaps, the smaller trout in the present study had a
relatively higher capacity to detoxify and/or eliminate TFM than their larger
counterparts, leading to less total accumulation of TFM compared to the larger fish
Effects of One-week Storage Methods on Postmortem Stability of TFM and its
Metabolites
Compared to snap freezing and storage at -80˚C, storage at -20˚C appears to
be equally as effective for preserving TFM in the tissues of non-target fishes for up
to a period of at least one week. While parent TFM levels in both species were not
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affected by storage at -20˚C, compared to snap-frozen tissues, the metabolites were
much less stable. After one week at -20˚C, levels of TFM-glucuronide and TFMsulfate in rainbow trout liver dropped about 90 and 60% respectively, suggesting
that hydrolytic enzymes in the liver such as the β-glucuronidase and sulfatases
might still be active at this temperature. These hydrolytic enzymes are normally
found inside lysosomes (Zhou and Byard, 2011; Mindell, 2012), which prevent them
from hydrolyzing newly generated TFM-glucuronide or TFM-sulfate arising from
conjugation reactions. However, at -20˚C it is likely that the formation of ice crystals
during freezing damages cellular membranes including those of lysosomes resulting
in the leakage of these and other enzymes into inter and extracellular spaces
(Rehbein and Çakli, 2000; Leygonie et al., 2012). As a result, any TFM metabolites
that had accumulated would be more susceptible to hydrolysis, and subsequent
degradation at this temperature. This would also be complicated by the longer time
needed for the sample to completely become completely frozen at -20°C compared
to snap freezing in liquid N2, which occurs almost instantaneously. With more time
for the enzymes to hydrolyze the TFM conjugates back into TFM, the relative
amounts of TFM-glucuronide and TFM-sulfate would be expected to be lower
following one week at -20˚C. This degradation could be further exacerbated if the
tissues were thawed during the homogenization of the tissues for extraction and
measurement of TFM and its metabolites.
After one week at storage temperatures of 4˚C (with or without preservative)
and at room temperature (with or without preservative), parent TFM and its
metabolites were almost completely degraded in rainbow trout and white sucker
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liver. The loss of TFM from the liver was likely due to autolysis and putrefaction
associated with more advanced decomposition that took place in the unfrozen tissue
over one week. Autolysis is the self-digestion of cells by intracellular enzymes and
putrefaction is the decomposition of cellular structures by microorganisms (Skopp,
2004; Butzbach 2010; Zhou and Byard, 2011). The liver is an enzyme-rich tissue due
to its role in detoxification (Bévalot et al., 2016), which can also become
contaminated with bacteria due to its close proximity to, as well as connection to the
intestines via the hepatic portal vein (Skopp, 2010, Bévalot et al., 2016).
In contrast to the liver, the relative stability of TFM in muscle of trout and
white sucker at 4°C, and to some extent at room temperature, was likely because of
its relative isolation from sources of bacteria, and a relative lack of endogenous
hydrolytic enzymes. However, at room temperature, muscle TFM was almost
completely degraded, although the presence of sodium fluoride preservative slowed
down the process somewhat.
Sodium fluoride (1 % in deionized water) is frequently used as a preservative
in forensic blood samples to prevent the breakdown different drugs including
paracetamol, cocaine, and benzodiazepines by inhibiting residual enzymatic and
microbial activity (Baselet, 1983; Mahjoub and Staub, 2000; Battal et al., 2013;
Butzbach, 2010). While NaF helped to preserve TFM in the white muscle of trout, it
had little effect on the stability of TFM or its metabolites in rainbow trout liver. This
may be because the solution was unable to fully penetrate the tissue in time to
prevent the rapid onset of decomposition that takes place in the liver compared to
the muscle..
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The increase in parent TFM concentrations that was observed in rainbow
trout blood with storage temperature suggests that endogenous hydrolytic enzymes
were active during one-week storage at 4˚C and room temperature. The
decomposition of blood occurs in a similar manner as described above as the onset
of hemolysis can occur rapidly after sampling (Forrest, 1993). White blood cells that
contain hydrolytic enzymes within lysosomes will inevitably rupture during
decomposition at elevated temperatures along with other blood cell membranes,
and could cause a release of cellular contents into the blood plasma resulting in the
hydrolysis of any TFM-glucuronide that was present in the blood as direct result of
TFM exposure (Fishman et al., 1947; Lorbacher et al., 1967; Avila and Convit,, 1973),
the net effect being increased concentrations of parent TFM.
The difference in stability of the TFM metabolites in the blood suggests that
the liberation of parent TFM comes primarily from hydrolysis of TFM-glucuronide
as the levels of TFM-sulfate remains relatively stable at elevated temperatures. In
contrast to liver and muscle, relative levels of TFM-sulfate in rainbow trout blood
were not affected by one week storage other than a slight decrease at room
temperature, perhaps due to the lower metabolic activity of blood compared to liver
and muscle, resulting in an overall lower decrease in pH as decomposition occurred
over one week, ultimately keeping levels of TFM-sulfate relatively stable.
While blood may not contain significant levels of conjugative enzymes due to
their role in detoxification being mainly limited to transportation of xenobiotics to
the liver it appears that decomposition of TFM-glucuronide occurs at an increasingly
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higher rate as temperatures increase, indicating that this metabolite is best
preserved at very low temperatures due to the inhibition of glucuronidase activity.
Method of Blood Sampling and Storage
To determine the effectiveness of different methods for storing whole blood
at 4˚C, vacutainers containing different preservatives and anticoagulants were
tested. These sterile test tubes are vacuum-sealed, allowing for the quick and easy
drawing of blood. The vacutainers are colour-coded universally, with each color
corresponding to the additives that are present in each tube. For instance, greencapped tubes contain lithium heparin, an anticoagulant that activates antithrombins
to inhibit the coagulation cascade (Bjork and Lindahl, 1982). Blue tubes contain,
sodium citrate, an anticoagulant that works by chelating calcium, which is needed
for clotting activity (Mollison, 2000). Finally, grey tubes contain sodium fluoride,
which as noted above reduces rates of metabolism of drugs in the blood by
enzymatic (Baselt, 1983) and microbial degradation (Butzbach, 2010). Grey tube
also contains sodium EDTA, another Ca2+-chelating agent that prevents clotting
(Bowen and Remaley, 2014).
Somewhat surprisingly, the concentration of TFM in the blood collected from
both trout and white sucker increased after one week at 4°C when lithium heparin
(green) or the combination of NaF plus EDTA (grey) were used. In contrast, the use
of sodium citrate (blue) effectively preserved parent TFM in whole blood at 4°C in
rainbow trout, but parent TFM was just above detection in white sucker suggesting
that there may be interspecies differences in the effectiveness of this blood
preservation technique. Given the life style and habitat differences between trout
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and white sucker, it is possible that the reduction of TFM in the latter was because of
different microbes present in the blood.
The upward trend in TFM concentration in the lithium heparin and
NaF/EDTA treated blood samples stored at 4˚C was coupled with decreases in TFMglucuronide and/or TFM-sulfate, which again suggest that hydrolytic enzymes
remained active under these conditions. If the goal is to simply obtain a semiquantitative measure of TFM in the blood, then collecting and preserving the
samples in lithium heparin would likely be the most-effect method. However, due to
the tendency of parent TFM concentrations to increase with this method, and with
Na citrate/EDTA treated vacutainers, interpretation would likely be limited to
presence or absence of TFM exposure. This could nevertheless be very important
when investigating fish kill events that take place following TFM applications.
Relevance for non-target mortality investigations
Where possible, liver, muscle and whole blood should be collected if nontarget fish mortalities take place during or after TFM application. The best way to
preserve blood and tissue samples for postmortem measurements of analytes is to
freeze the samples as fast as possible in liquid N2, and keep them frozen at -80°C
until analysis (Wang et al., 1994; Butzbach, 2010). However, sea lamprey control
agents or investigators in the field may not have access to liquid N2 or dry ice, which
would likely be a suitable alternative. Thus, keeping the samples on ice until they
can be stored at -20°C or shipped to investigative laboratories on dry ice, would be
an acceptable alternative. Samples can be kept at room temperature for periods of
up to 1 hour, but this would be considered the least desirable option. Storage of
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samples at room temperature, even with NaF preservative, is ineffective. Under such
sub-optimal storage conditions, the concentrations of TFM can be drastically altered
due to the degradation of TFM in the liver, and the degradation of TFM metabolites
can lead to marked increases in blood TFM concentration. While liver would be the
tissue of choice under optimal conditions, because it is prone to decomposition, it
should be rapidly frozen and stored at -20°C until shipped to the lab. In less than
optimal conditions, muscle appears to be the most reliable tissue for forensic
analysis when TFM is the suspected cause of a fish kill. If blood can be samples from
living or recently killed fish, vacutainers containing either lithium heparin or
NaF/EDTA would be the best option because TFM and its metabolites appear to be
stable in blood under even sub-optimal storage conditions for at least one week.
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Table 3-1. Percent water measured in rainbow trout muscle and liver from
Series 2: Effects of Storage Methods on Postmortem Stability of TFM and its
metabolites. Tissues were dried to a constant mass at 60°C and corresponding
percent water content was then calculated. All data are expressed as the mean ±
1 SEM (N = 8). Asterisks denote significant difference from snap-frozen values.

Treatment

Muscle % Water Liver % Water

Snap-Frozen

76.4 ± 1.3 (8)

76.9 ± 0.6 (8)

-20˚C

78.3 ± 0.5 (8)

76.6 ± 0.6 (8)

4˚C (+ NaF)

85.6 ± 0.7 (8) *

87.1 ± 0.4 (8) *

4˚C (- NaF)

79.7 ± 0.6 (8)

75.1 ± 0.4 (8)

Room Temperature (+NaF)

86.2 ± 0.9 (8) *

89.0 ± 1.6 (8) *

Room Temperature (-NaF)

79.1 ± 0.7 (8)

75.4 ± 1.7 (8)
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Figure 3-1. Effects of different collection and handling methods on
postmortem stability of TFM and its metabolites in rainbow trout blood
and tissues. A) Quantification of 3-trifluoromethyl-4-nitrophenol (TFM) in liver,
muscle and blood of rainbow trout (Oncorhynchus mykiss) exposed to their predetermined 9-h LC25 (12.9 mg l-1 TFM). Blood and tissues from each fish were
separated into 3 different aliquots and either snap-frozen in liquid N2, kept on
ice for one hour or kept at room temperature for one hour. Relative signal area
of (B) TFM-glucuronide conjugate and (C) TFM-sulfate conjugate in the same
tissues of rainbow trout that were either snap-frozen in liquid N2, kept on ice for
one hour or kept at room temperature for one hour. The metabolite signal areas
of samples kept on ice or at room temperature were normalized by expressing
values as a percentage of values obtained from the snap-frozen (liquid N2)
samples. All data are expressed as the mean + 1 SEM (N = 10). Bars sharing the
same letter are not significantly different from one another (P < 0.05).
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Figure 3-2. Effects of different collection and handling methods on
postmortem stability of TFM and its metabolites in white sucker blood and
tissues. A) Quantification of 3-trifluoromethyl-4-nitrophenol (TFM) in liver,
muscle and blood of white sucker (Catostomus commersonii) exposed to their
pre-determined 9-h LC25 (18.88 mg l-1 TFM). Blood and tissues from each fish
separated into 3 different aliquots and either snap-frozen in liquid N2, kept on
ice for one hour or kept at room temperature for one hour. Relative signal area
of (B) TFM-glucuronide conjugate and (C) TFM-sulfate conjugate in the same
tissues of white sucker that were either snap-frozen in liquid N2 kept on ice for
one hour or kept at room temperature for one hour. The metabolite signal areas
of samples kept on ice or at room temperature were normalized by expressing
values as a percentage of values obtained from the snap-frozen (liquid N2)
samples. All data are expressed as the mean + 1 SEM (N = 10). Bars sharing the
same letter are not significantly different from one another (P < 0.05).
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Figure 3-3. Effects of different storage methods on postmortem stability of
TFM and its metabolites in the blood and tissues of rainbow trout. A)
Quantification of 3-trifluoromethyl-4-nitrophenol (TFM) in liver, muscle and
blood of rainbow trout (Oncorhynchus mykiss) exposed to their pre-determined
9-h LC25 (12.9 mg l-1 TFM). Blood and tissues from each fish separated into 6
different aliquots and either snap-frozen in liquid N2 or kept at -20˚C, 4˚C with
NaF preservative, 4˚C without NaF preservative, room temperature with NaF
preservative, or room temperature without NaF preservative for one week.
Relative signal area of (B) TFM-glucuronide conjugate and (C) TFM-sulfate
conjugate in the same tissues and treatments as above. The metabolite signal
areas of all samples kept on at -20˚C, 4˚C and room temperature were
normalized by expressing their values as a percentage of values obtained from
the snap-frozen (liquid N2) samples. All data are expressed as the mean + 1 SEM
(N = 10). Bars sharing the same letter are not significantly different from one
another (P < 0.05).
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Figure 3-4. Effects of different storage methods on postmortem stability of
TFM and its metabolites in the blood and tissues of white sucker. A)
Quantification of 3-trifluoromethyl-4-nitrophenol (TFM) in liver, muscle and
blood of white sucker (Catostomus commersonii) exposed to their predetermined 9-h LC25 (18.88 mg l-1 TFM). Blood and tissues from each fish
separated into 6 different aliquots and either snap-frozen in liquid N2 or kept at 20˚C, 4˚C without NaF preservative, or room temperature without NaF
preservative for one week. Relative signal area of (B) TFM-glucuronide
conjugate and (C) TFM-sulfate conjugate in the same tissues and treatments as
above. The metabolites signal areas of samples kept at-20˚C, 4˚C and at room
temperature were normalized by expressing their values as a percentage of the
values obtained from the snap-frozen (liquid N2) samples. All data are expressed
as the mean + 1 SEM (N = 10). Bars sharing the same letter are not significantly
different from one another (P < 0.05)
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Figure 3-5. Effects of anticoagulants and preservatives on the stability of
TFM and its metabolites in rainbow trout blood. A) Quantification of 3trifluoromethyl-4-nitrophenol (TFM) in the blood of rainbow trout
(Oncorhynchus mykiss) exposed to their pre-determined 9-h LC25 (12.9 mg l-1
TFM). Blood from each fish was separated into 4 different aliquots and either
snap-frozen in liquid N2 or kept in one of 3 different vacutainers and kept at 4˚C
for one week. The three types of containers contained (i) lithium heparin
(green), (ii) 0.109 M sodium citrate (blue) and (iii) NaF and Na2
Ethylenediaminetetraacetic acid (EDTA; grey). Relative signal area of (B) TFMglucuronide conjugate and (C) TFM-sulfate conjugate in the same tissues and
treatments. The metabolite signal areas of samples kept in vacutainers were
normalized by expressing their values as a percentage of values obtained from
the snap-frozen (liquid N2) samples. All data are expressed as the mean + 1 SEM
(N = 10). Bars sharing the same letter are not significantly different from one
another (P < 0.05).
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Figure 3-6. Effects of anticoagulants and preservatives on the stability of
TFM and its metabolites in white sucker blood. A) Quantification of 3trifluoromethyl-4-nitrophenol (TFM) in the blood of white sucker (Catostomus
commersonii) exposed to their pre-determined 9-h LC25 (18.88 mg l-1 TFM).
Blood from each fish was separated into 4 different aliquots and either snapfrozen in liquid N2 or kept in one of 3 different vacutainers and kept at 4˚C for
one week. The three types of containers contained (i) lithium heparin (green),
(ii) 0.109 M sodium citrate (blue) and (iii) NaF and Na2
Ethylenediaminetetraacetic acid (EDTA; grey). Relative signal area of (B) TFMglucuronide conjugate and (C) TFM-sulfate conjugate in the same tissues and
treatments. The metabolite signal areas of samples kept in vacutainers were
normalized by expressing their values as a percentage of values obtained from
the snap-frozen (liquid N2) samples. All data are expressed as the mean + 1 SEM
(N = 10). Bars sharing the same letter are not significantly different from one
another (P < 0.05).
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Chapter 4:
Integrated Tissue Sampling Protocol for the Postmortem Measurement of TFM
and its Metabolites
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Introduction
The lampricide 3-trifluoromethyl-4-nitrophenol (TFM) is selectively toxic
to larval sea lampreys (Petromyzon marinus) due to their lower capacity to
detoxify the compound via glucuronidation and sulfation compared to other
non-target fishes (Lech, 1974; Lech and Statham, 1975; Kane et al., 1994; Bussy
et al., 2017b). During typical stream treatments, TFM is applied at
concentrations that are sub-lethal to most non-target fishes, however,
unexpected events such as sudden drops in water pH or changes in water flow
could increase the bioavailability and toxicity of TFM resulting in non-target
mortality (Bills et al. 2003; Boogaard et al 2003; McDonald and Kolar, 2007).
Other, unrelated factors including disease, contamination, oxygen depletion and
drastic temperature changes could also cause death to fishes (Meyer and
Barclay, 1990). Therefore in situations when the cause of death is uncertain,
measuring tissue levels of TFM and its metabolites could provide insight into
whether or not TFM played a role in the death of the fishes. The present thesis
provides qualitative and quantitative data on the forensic markers of lampricide
toxicity for the facilitation of non-target morality investigations.
Current Sampling and Storage Protocols and Areas of Improvement
Cold temperatures are known to slow down the process of decomposition
that inevitably occurs in tissues following death. However, little is known about
the effects that various storage techniques, as well as how different tissues can
affect the stability of TFM and its metabolites. The Great Lakes Fishery
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Commission currently has standard operating procedures (SOPs) in place for the
collection, handling and storage of fish samples when it is not obvious whether
or not non-target mortality is due to lampricide exposure. The procedures
include the collection of blood, muscle and liver, and storage of all samples on ice
(or dry ice if it available) for delivery to UMESC and subsequent analysis of
lampricide concentrations (Great Lakes Fishery Commission, 2016). In some
cases, dry ice may not be available on site, or within a reasonable distance of the
fish kill. It is therefore imperative to ascertain whether or not TFM and its
metabolites are stable under sub-optimal storage conditions, and which tissues
are most reliable in the case when optimal storage is not an option.
While it would be difficult to be able to conclude for certain that an
internal concentration of TFM or any of its metabolites are indicative of TFM
toxicity, especially if the fish kill was not observed for a few days, data
comparing various external exposure concentrations with corresponding
internal tissue concentrations could provide a valuable reference for these
investigations. This thesis set out to characterize how the internal distribution of
TFM and its metabolites are affected by various exposure concentrations, and
whether or not these measurements can provide useful information that can
help distinguish between death caused by lampricide toxicity and death caused
by other possible factors for the investigations unexplained fish kills that
coincide with lampricide applications. A second major goal of this thesis was to
provide further recommendations for the collection, handling and storage of
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blood and tissue samples to be incorporated into current standard operating
procedures for investigations of unexplained non-target mortality.
Legal Implications
Tissue samples are collected in the case of a moderate to major fish kill,
which is defined as 100 or more non-target fish deaths per 1.6 km (Great Lakes
Fishery Commission, 2016). Besides taking biological samples from up to 20 of
each species of fish found dead, water samples are collected along with
quantifying the number of dead fish, recording properties of water chemistry
and completing a number of different fish kill investigation forms found in
TOP:026.8: Protocol for investigations of and responses to unexplained mortality
of non-target fish. The collection of samples and the recording of all data is very
important and must be performed following outlined procedures because it
could possibly be used in legal proceedings, including cases of civil litigation, or
in a worse case scenario, criminal proceedings in the event that charges are laid
by government authorities in Canada or the United States. It is therefore critical
that all samples must follow chain of custody to ensure the integrity of the
evidence that is provided by the tissue samples during the investigation. Data
from this thesis will help augment these sampling procedures to ensure that the
tissues are stored and shipped in a manner so that the chain of custody is
maintained and the samples are reliable and admissible for legal proceedings.
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What Concentrations of TFM Could Cause Death in Non-Target Fishes
The observation of a “spill over” effect that occurs in blood and muscle
when the detoxification capacity of the liver becomes overwhelmed due to
exposure to lethal concentrations of TFM could have major implications in
improving the quality of information that is gathered from this analysis. By
measuring TFM concentrations in the blood, muscle and liver it may be possible
to determine a lethal threshold for each of these tissues, namely a threshold in
which the uptake of TFM will be too high for the liver to actively detoxify at a
rate high enough to prevent spill over of the TFM into general circulation,
ultimately causing death due to the inhibition of mitochondrial ATP production
(Birceanu et al., 2011). In agreement with the current protocol for collection of
tissues from non-target fishes (Appendix D; TOP:026.8; Great Lakes Fishery
Commission, 2016), liver, muscle and blood (whole), should be collected, along
with water samples to determine approximate exposure concentrations, which
could be compared to charts similar to Figure 2-5 to determine if the tissue
thresholds were exceeded, which would indicate whether or not TFM toxicity
could have caused death.
Quickly collecting blood and tissue samples directly after death and
freezing the samples as soon as possible would be the ideal scenario to generate
samples for the reliable determination of TFM that could cause death. However,
in the case of non-target mortality, this is typically not the case because
mortalities could go unobserved for some time, and ideal sampling and storage
conditions might not always be available or practical. A a recent study by White
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(2018) found that whole body decomposition of rainbow trout in warm water
(20˚C) causes a significant decrease in TFM levels in muscle and liver by 40-50%.
At 4˚C, however, TFM concentrations in trout muscle and liver were no different
from control levels of fish sampled immediately after death. It was also noteworthy that TFM was more stable in muscle than in the liver, suggesting that
muscle may be the most reliable and important sample to collect, followed by
liver and blood, when conditions are less than optimal (Figure 4-1; e.g. no
refrigeration available; lack of ice).
The current GLFC SOP for sample collection also directs investigators to
freeze samples as quickly as possible. The present study supports this practice,
but it also demonstrates that even under sub-optimal conditions, measurements
of value can be collected from the muscle, liver and blood. However, in both liver
and blood, the quantification of TFM becomes highly complicated and less
reliable because liver concentrations of TFM decrease, and TFM increases in
blood if the samples remain at room temperature or 4°C for more than 24 h.
Thus, it is crucial to note with care the sampling conditions and storage
conditions of tissues so that the most accurate interpretation of TFM values
possible are obtained.
Implications for the Great Lakes
One of the major goals of the Great Lakes Fishery Commissions Integrated
Sea Lamprey Control program is to increase the effectiveness and efficiency of
sea lamprey control to further reduce populations of sea lampreys in the Great
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Lakes (Great Lakes Fishery Commission, 2017). Application of TFM in the
tributaries of the Great Lakes is the backbone of sea lamprey control, and its
effectiveness is highly dependent on applying a concentration high enough to kill
as close to 100% of the lampreys present as possible. While harm to non-target
fish can occur at higher concentrations, allowing the survival of a significant
number sea lampreys can have far greater implications not only to those nontarget fishes in the streams where the applications take place, but in the greater
ecosystem of the Great Lakes. The ability to rule out TFM as the cause of a major
non-target fish kill is imperative to the continuing success of the sea lamprey
control program because a fish kill at a large enough scale, not to mention one
that harms endangered or culturally significant species of fish could have major
consequences like charges laid by Canadian or American Governments and/or
retraction of funding for future programs. By improving sampling, handling and
storage protocols for the analysis of non-target fish tissues in the case of
unexplained mortality, greater reliability and confidence in the measurements of
lampricides could provide stronger cases for the role that TFM has played in the
death of the fishes.
Further Directions
Further research should be aimed at providing measurement of TFM and
its metabolites in the blood and tissues of other non-target fishes that may be
exposed to lethal concentrations of TFM. If a database on the internal thresholds
of TFM in the different tissues can be built for a range of species, it could provide
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a reliable resource to help ascertain if TFM could have caused death in instances
of non-target mortality. Indeed the difference in stability of TFM in white sucker
and rainbow trout liver after 1 h suggests that there could be substantial
variation in the stability of TFM in the tissues of other species. For this reason it
might be appropriate to develop specific storage protocols for different species.
Further study could also be useful for determining the effectiveness of sodium
fluoride preservative at different strengths for storage of blood and plasma.
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Figure 4-1. Recommended biological sample collection and preservation for
the investigation of unexplained non-target mortality. After an unexplained fish
kill that coincides with a lampricide treatment, investigations are conducted and
include the collection of biological samples for the measurement of lampricide
concentrations to determine the cause of death of the fishes. While blood, liver and
muscle can all be used to determine if fish were exposed to lampricides, not all
measurements of TFM in these tissues will be reliable if they are stored at suboptimal conditions before analysis. To accurately determine if lampricides
contributed to death of the fishes, sub-optimal storage of blood and liver is not
recommended, while muscle can be stored on ice or at 4˚C for up to one week.
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Unexplained fish kill

Sample
Blood (if possible)

Muscle
Liver

Dry ice?
Dry ice?
Dry ice?

Yes

No

Yes
Yes

Keep on dry ice
until storage at
-20˚C or colder
Sub-optimal storage not
recommended but can indicate
TFM exposure if stored on ice or at
4˚C in green or grey vacutainer for
less than 1 week

No

No
Keep on dry ice
until storage at
-20˚C or colder

Keep on dry ice
until storage at
-20˚C or colder
Sub-optimal storage not
recommended but can
indicate TFM exposure if
stored for less than 1 hour
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Keep on ice or at 4˚C for up
to 1 week

Appendix A
List of Abbreviations
TFM

3-trifluoromethyl-4-nitrophenol

GLFC

Great Lakes Fishery Commission

MLC

Minimum lethal concentration

ATP

Adenosine triphosphate

UDPGT

Uridine diphosphate glucuronyltransferase

PST

Phenol sulfotransferase

PAPS

3’-phosphate 5’-phosphosulphate

APHA

American Public Health Association

FWS

United States Fish and Wildlife Service

DFO

Department of Fisheries and Oceans Canada

UMESC

Upper Midwest Environmental Sciences Center

LC

Liquid Chromatography

MS

Mass Spectrometry

Q-TOF

Quadrupole Time-of-Flight

CCAC

Canadian Council on Animal Care

DO

Dissolved Oxygen

MS222

Tricaine methanesulfonate

EC

Extraction coefficient

DF

Dilution factor

ANOVA

Analysis of Variance
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SEM

Standard error of the mean

CI

95% Confidence interval

MCHC

Mean cell hemoglobin concentration

EDTA

Ethylenediaminetetraacetic acid

NAD+ -

Nicotinamide adenine dinucleotide
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Appendix B
P-values
Rainbow trout tissue distribution
Parent TFM
Tissue comparison
Liver - Muscle
Liver - Whole blood
Liver - Plasma
Liver - RBC pellet
Muscle - Whole blood
Muscle - plasma
Muscle - RBC pellet
Whole blood - Plasma
Whole blood - RBC pellet
Plasma - RBC pellet

p-value
<.01
<.01
<.01
<.01
0.38
<.01
<.01
<.01
<.01
<.01

TFM-OG
Tissue comparison
Liver - Muscle
Liver - Whole blood
Liver - Plasma
Liver - RBC pellet
Muscle - Whole blood
Muscle - plasma
Muscle - RBC pellet
Whole blood - Plasma
Whole blood - RBC pellet
Plasma - RBC pellet

p-value
0.0000
0.0024
0.0271
0.0000
0.0034
0.0002
0.3501
0.1859
0.0102
0.0007

TFM-OS
Tissue comparison
Liver - Muscle
Liver - Whole blood
Liver - Plasma
Liver - RBC pellet
Muscle - Whole blood
Muscle - plasma
Muscle - RBC pellet
Whole blood - Plasma
Whole blood - RBC pellet
Plasma - RBC pellet

p-value
0.0001
0.1262
0.3881
0.1724
0.0000
0.0000
0.0032
0.1948
0.0184
0.1096
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White sucker tissue distribution
Parent TFM
Tissue Comparison
Muscle – Liver
Blood - Liver
Blood - Muscle

p-value
<.01
<.01
.34

TFM-OG
Tissue Comparison
Muscle – Liver
Blood - Liver
Blood - Muscle

p-value
<.01
<.01
<.01

Tissue Comparison
Muscle – Liver
Blood - Liver
Blood - Muscle

p-value
.02
0.67
<.01

TFM-OS

Dose dependent changes in the distribution of TFM in rainbow trout tissues
Parent TFM
Alive fish - Liver
Exposure Concentration Comparison
p-value
(mg l-1)
11.3 - 5.5
0.9583094
16.5 - 5.5
0.9999979
21.9 - 5.5
0.6801090
25.3 - 5.5
0.0052211**
16.5- 11.3
0.9617530
21.9 - 11.3
0.3712477
25.3 - 11.3
0.0011885**
21.9 -16. 5
0.6355750
25.3 -16.5
0.0037964**
25.3 -21. 9
0.2283349
Parent TFM
Alive fish - Muscle
Exposure Concentration Comparison
(mg l-1)
11.3 - 5.5
16.5 - 5.5
21.9 - 5.5
25.3 - 5.5
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p-value
0.0000286
0.0000000
0.0000000
0.0000062

16.5 -11.3
21.9 -11.3
25.3 -11.3
21.9 -16.5
25.3 -16.5
25.3 - 21.9

0.0000239
0.0014261
0.0707421
0.9691163
0.9942229
0.9293646

Parent TFM
Alive fish - Blood
Exposure Concentration Comparison
(mg l-1)
11.3 - 5.5
16.5 - 5.5
21.9 - 5.5
25.3 - 5.5
16.5 -11.3
21.9 -11.3
25.3 -11.3
21.9 -16.5
25.3 -16.5
25.3 - 21.9
Parent TFM
Dead fish - Liver
Exposure Concentration Comparison
(mg l-1)
25.3 - 21.9
31 - 21.9
31 - 25.3
Parent TFM
Dead fish - Muscle
Exposure Concentration Comparison
(mg l-1)
25.3 - 21.9
31 - 21.9
31 - 25.3
Parent TFM
Dead fish - Blood
Exposure Concentration Comparison
(mg l-1)
25.3 - 21.9
31 - 21.9
31 - 25.3
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p-value
0.2679474
0.0084949
0.0002308
0.0016867
0.5813251
0.0128039
0.0447665
0.1325901
0.2687082
0.9999843

p-value
0.1202222
0.3908462
0.6409272

p-value
0.9255447
0.9656749
0.9882983

p-value
0.82
0.92
0.93

Parent TFM
Dead vs. alive - Liver
Exposure Concentration Comparison
(mg l-1)
21.9
25.3
Parent TFM
Dead vs. alive - Muscle
Exposure Concentration Comparison
(mg l-1)
21.9
25.3
Parent TFM
Dead vs. alive - Blood
Exposure Concentration Comparison
(mg l-1)
21.9
25.3
TFM-OG
Alive fish - Liver
Exposure Concentration Comparison
(mg l-1)
11.3 - 5.5
16.5 - 5.5
21.9 - 5.5
25.3 - 5.5
16.5- 11.3
21.9 - 11.3
25.3 - 11.3
21.9 -16. 5
25.3 -16.5
25.3 -21. 9
TFM-OG
Alive fish - muscle
Exposure Concentration Comparison
(mg l-1)
11.3 - 5.5
16.5 - 5.5
21.9 - 5.5
25.3 - 5.5
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p-value
0.8782
0.576

p-value
0.00914
0.0005057

p-value
0.06955
0.01103

p-value
0.0057
0.0000
0.0002
0.0042
0.0125
0.0289
0.1199*
0.3286*
0.4529*
0.3355*

p-value
.67
<.01
<.01
<.01

16.5- 11.3
21.9 - 11.3
25.3 - 11.3
21.9 - 16. 5
25.3 - 16.5
25.3 -21. 9

.06
<.01
.07
.02
.99
.01

TFM-OG
Alive fish - blood
Exposure Concentration Comparison
(mg l-1)
11.3 - 5.5
16.5 - 5.5
21.9 - 5.5
25.3 - 5.5
16.5- 11.3
21.9 - 11.3
25.3 - 11.3
21.9 -16. 5
25.3 -16.5
25.3 -21. 9
TFM-OG
Dead fish - Liver
Exposure Concentration Comparison
(mg l-1)
25.3 - 21.9
31 - 21.9
31 - 25.3
TFM-OG
Dead fish - Muscle
Exposure Concentration Comparison
(mg l-1)
25.3 - 21.9
31 - 21.9
31 - 25.3
TFM-OG
Dead fish - Blood
Exposure Concentration Comparison
(mg l-1)
25.3 - 21.9
31 - 21.9
31 - 25.3
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p-value
0.1262564
0.0000004
0.0000360
0.0000138
0.0014251
0.0054605
0.0013832
0.8557336
0.4166185
0.9527528

p-value
0.6691551
0.1127327
0.0121414

p-value
0.3018
0.0001
0.0004

p-value
.85
.01
.02

TFM-OG
Dead vs. alive - Liver
Exposure Concentration Comparison
(mg l-1)
21.9
25.3
TFM-OG
Dead vs. alive - Muscle
Exposure Concentration Comparison
(mg l-1)
21.9
25.3
TFM-OG
Dead vs. alive - Blood
Exposure Concentration Comparison
(mg l-1)
21.9
25.3
TFM-OS
Alive fish - Liver
Exposure Concentration Comparison
(mg l-1)
11.3 - 5.5
16.5 - 5.5
21.9 - 5.5
25.3 - 5.5
16.5- 11.3
21.9 - 11.3
25.3 - 11.3
21.9 -16. 5
25.3 -16.5
25.3 -21. 9
TFM-OS
Alive fish - muscle
Exposure Concentration Comparison
(mg l-1)
11.3 - 5.5
16.5 - 5.5
21.9 - 5.5
25.3 - 5.5

124

p-value
0.4065
0.1617

p-value
0.05731
0.4655

p-value
0.5515
0.1518

p-value
0.0052
0.0000
0.0053
0.1466
0.0148
0.1860
0.3343
0.3018
0.0460
0.1557

p-value
0.0512394
0.0000001
0.0000000
0.0200320

16.5- 11.3
21.9 - 11.3
25.3 - 11.3
21.9 - 16. 5
25.3 - 16.5
25.3 -21. 9

0.0010363
0.0000058
0.5269505
0.0304156
0.9076576
0.0373940

TFM-OS
Alive fish - blood
Exposure Concentration Comparison
(mg l-1)
11.3 - 5.5
16.5 - 5.5
21.9 - 5.5
25.3 - 5.5
16.5- 11.3
21.9 - 11.3
25.3 - 11.3
21.9 -16. 5
25.3 -16.5
25.3 -21. 9
TFM-OS
Dead fish - Liver
Exposure Concentration Comparison
(mg l-1)
25.3 - 21.9
31 - 21.9
31 - 25.3
TFM-OS
Dead fish - Muscle
Exposure Concentration Comparison
(mg l-1)
25.3 - 21.9
31 - 21.9
31 - 25.3
TFM-OS
Dead fish - Blood
Exposure Concentration Comparison
(mg l-1)
25.3 - 21.9
31 - 21.9
31 - 25.3
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p-value
0.0363
0.0000
0.0000
0.0150
0.0028
0.0004
0.1284
0.0632
0.3206
0.0653

p-value
0.2942
0.0077
0.0010

p-value
0.8401628
0.0986484
0.2701480

p-value
0.4590045
0.0177448
0.2340224

TFM-OS
Dead vs. alive - Liver
Exposure Concentration Comparison
(mg l-1)
21.9
25.3
TFM-OS
Dead vs. alive - Muscle
Exposure Concentration Comparison
(mg l-1)
21.9
25.3
TFM-OS
Dead vs. alive - Blood
Exposure Concentration Comparison
(mg l-1)
21.9
25.3

p-value
0.3336
0.1859

p-value
0.05728
0.5014

p-value
0.4675
0.08471

Chapter 3
One-hour storage techniques
Parent TFM
Rainbow trout – Liver
Treatment comparison
Snap-Frozen – Ice
Snap-Frozen – Room Temp.
Ice – Room Temp.

p-value
0.0399455
0.7646412
0.0080712

Parent TFM
Rainbow trout – Muscle
Treatment comparison
Snap-Frozen – Ice
Snap-Frozen – Room Temp.
Ice – Room Temp.

p-value
0.9967155
0.8202734
0.8599578

Parent TFM
Rainbow trout – Blood
Treatment comparison
Snap-Frozen – Ice
Snap-Frozen – Room Temp.
Ice – Room Temp.

p-value
0.4887906
0.9438065
0.6859794
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TFM-OG
Rainbow trout – Liver
Treatment comparison
Snap-Frozen – Ice
Snap-Frozen – Room Temp.
Ice – Room Temp.

p-value
.62
.02
.02

TFM-OG
Rainbow trout – Muscle
Treatment comparison
Snap-Frozen – Ice
Snap-Frozen – Room Temp.
Ice – Room Temp.

p-value
0.3910163
0.3758350
0.9995344

TFM-OG
Rainbow trout – Blood
Treatment comparison
Snap-Frozen – Ice
Snap-Frozen – Room Temp.
Ice – Room Temp.

p-value
0.4527
0.0578
0.0728

TFM-OS
Rainbow trout – Liver
Treatment comparison
Snap-Frozen – Ice
Snap-Frozen – Room Temp.
Ice – Room Temp.

p-value
0.9997087
0.9272097
0.9356394

TFM-OS
Rainbow trout – Muscle
Treatment comparison
Snap-Frozen – Ice
Snap-Frozen – Room Temp.
Ice – Room Temp.

p-value
0.2442
0.0389
0.1421

TFM-OS
Rainbow trout – Blood
Treatment comparison
Snap-Frozen – Ice
Snap-Frozen – Room Temp.
Ice – Room Temp.

p-value
0.8503111
0.9791039
0.9354114

127

Parent TFM
White sucker – Liver
Treatment comparison
Snap-Frozen – Ice
Snap-Frozen – Room Temp.
Ice – Room Temp.

p-value
0.5162217
0.6023828
0.1149167

Parent TFM
White sucker – Muscle
Treatment comparison
Snap-Frozen – Ice
Snap-Frozen – Room Temp.
Ice – Room Temp.

p-value
0.6382117
0.0926962
0.0129017

Parent TFM
White sucker – Blood
Treatment comparison
Snap-Frozen – Ice
Snap-Frozen – Room Temp.
Ice – Room Temp.

p-value
0.1473842
0.3094014
0.0063128

TFM-OG
White sucker – Liver
Treatment comparison
Snap-Frozen – Ice
Snap-Frozen – Room Temp.
Ice – Room Temp.

p-value
0.1175
0.0007
0.0233

TFM-OG
White sucker – Muscle
Treatment comparison
Snap-Frozen – Ice
Snap-Frozen – Room Temp.
Ice – Room Temp.

p-value
0.9744073
0.2873049
0.2027739

TFM-OG
White sucker – Blood
Treatment comparison
Snap-Frozen – Ice
Snap-Frozen – Room Temp.
Ice – Room Temp.

p-value
0.8358935
0.9821298
0.9191391
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TFM-OS
White sucker – Liver
Treatment comparison
Snap-Frozen – Ice
Snap-Frozen – Room Temp.
Ice – Room Temp.

p-value
0.0955
0.0188
0.2199

TFM-OS
White sucker – Muscle
Treatment comparison
Snap-Frozen – Ice
Snap-Frozen – Room Temp.
Ice – Room Temp.

p-value
0.9101754
0.0424586
0.0989332

TFM-OS
White sucker – Blood
Treatment comparison
Snap-Frozen – Ice
Snap-Frozen – Room Temp.
Ice – Room Temp.

p-value
0.2183
0.4298
0.2739

One-week storage Techniques
Parent TFM
Rainbow Trout - Liver
Treatment comparison
Snap-Frozen – -20˚C
Snap-Frozen – 4˚ C (+NaF)
Snap-Frozen – 4˚ C (- NaF)
Snap-Frozen – Room temp. (+NaF)
Snap-Frozen – Room temp. (- NaF)
-20˚C – 4˚ C (+NaF)
-20˚C – 4˚ C (-NaF)
-20˚C – Room temp. (+NaF)
-20˚C – Room temp. (- NaF)
4˚ C (+NaF) – 4˚ C (-NaF)
4˚ C (+NaF) – Room temp. (+NaF)
4˚ C (+NaF) – Room temp. (- NaF)
4˚ C (- NaF) – Room temp. (+NaF)
4˚ C (- NaF) – Room temp. (- NaF)
Room temp. (+NaF) – Room temp. (- NaF)
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p-value
0.3605
0.0005
0.0117
0.0000
0.0008
0.0001
0.0043
0.0000
0.0002
0.1544
0.1587
0.4503
0.0218
0.1860
0.1303

Parent TFM
Rainbow trout - Muscle
Treatment comparison
Snap-Frozen – -20˚C
Snap-Frozen – 4˚ C (+NaF)
Snap-Frozen – 4˚ C (- NaF)
Snap-Frozen – Room temp. (+NaF)
Snap-Frozen – Room temp. (- NaF)
-20˚C – 4˚ C (+NaF)
-20˚C – 4˚ C (-NaF)
-20˚C – Room temp. (+NaF)
-20˚C – Room temp. (- NaF)
4˚ C (+NaF) – 4˚ C (-NaF)
4˚ C (+NaF) – Room temp. (+NaF)
4˚ C (+NaF) – Room temp. (- NaF)
4˚ C (- NaF) – Room temp. (+NaF)
4˚ C (- NaF) – Room temp. (- NaF)
Room temp. (+NaF) – Room temp. (- NaF)

p-value
0.2106
0.0579
0.4857
0.0030
0.0001
0.2211
0.2004
0.0257
0.0019
0.0538
0.1191
0.0167
0.0026
0.0001
0.1717

Parent TFM
Rainbow trout - Blood - temperatures
Treatment comparison
Snap-Frozen – -20˚C
Snap-Frozen – 4˚ C
Snap-Frozen – Room temp.
-20˚C – 4˚ C
-20˚C – Room temp.
4˚ C – Room temp.

p-value
0.9371841
0.0203747
0.0000633
0.0679020
0.0002593
0.1591646

Parent TFM
Rainbow trout - Blood - vacutainers
Treatment comparison
Snap-Frozen – Green
Snap-Frozen – Blue
Snap-Frozen – Grey
Green – Blue
Green – Grey
Blue – Grey

p-value
0.0042802
0.3648472
0.0003679
0.1535785
0.7646271
0.0191225
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TFM-OG
Rainbow Trout - Liver
Treatment comparison
Snap-Frozen – -20˚C
Snap-Frozen – 4˚ C (+NaF)
Snap-Frozen – 4˚ C (- NaF)
Snap-Frozen – Room temp. (+NaF)
Snap-Frozen – Room temp. (- NaF)
-20˚C – 4˚ C (+NaF)
-20˚C – 4˚ C (-NaF)
-20˚C – Room temp. (+NaF)
-20˚C – Room temp. (- NaF)
4˚ C (+NaF) – 4˚ C (-NaF)
4˚ C (+NaF) – Room temp. (+NaF)
4˚ C (+NaF) – Room temp. (- NaF)
4˚ C (- NaF) – Room temp. (+NaF)
4˚ C (- NaF) – Room temp. (- NaF)
Room temp. (+NaF) – Room temp. (- NaF)

p-value
0.1481
0.0000
0.0000
0.0000
0.0000
0.0002
0.0006
0.0002
0.0002
0.3691
0.5000
0.5000
0.3691
0.3691
0.5000

TFM-OG
Rainbow trout - Muscle
Treatment comparison
Snap-Frozen – -20˚C
Snap-Frozen – 4˚ C (+NaF)
Snap-Frozen – 4˚ C (- NaF)
Snap-Frozen – Room temp. (+NaF)
Snap-Frozen – Room temp. (- NaF)
-20˚C – 4˚ C (+NaF)
-20˚C – 4˚ C (-NaF)
-20˚C – Room temp. (+NaF)
-20˚C – Room temp. (- NaF)
4˚ C (+NaF) – 4˚ C (-NaF)
4˚ C (+NaF) – Room temp. (+NaF)
4˚ C (+NaF) – Room temp. (- NaF)
4˚ C (- NaF) – Room temp. (+NaF)
4˚ C (- NaF) – Room temp. (- NaF)
Room temp. (+NaF) – Room temp. (- NaF)

p-value
0.4767
0.0005
0.0007
0.0000
0.0000
0.0006
0.0009
0.0000
0.0000
0.4535
0.1826
0.1826
0.1534
0.1534
0.5000
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TFM-OG
Rainbow trout - Blood - temperatures
Treatment comparison
Snap-Frozen – -20˚C
Snap-Frozen – 4˚ C
Snap-Frozen – Room temp.
-20˚C – 4˚ C
-20˚C – Room temp.
4˚ C – Room temp.

p-value
0.4460
0.0525
0.0001
0.0400
0.0001
0.0285

TFM-OG
Rainbow trout - Blood - vacutainers
Treatment comparison
Snap-Frozen – Green
Snap-Frozen – Blue
Snap-Frozen – Grey
Green – Blue
Green – Grey
Blue – Grey

p-value
0.0653
0.0034
0.0000
0.1077
0.0004
0.0182

TFM-OS
Rainbow trout - Liver
Treatment comparison
Snap-Frozen – -20˚C
Snap-Frozen – 4˚ C (+NaF)
Snap-Frozen – 4˚ C (- NaF)
Snap-Frozen – Room temp. (+NaF)
Snap-Frozen – Room temp. (- NaF)
-20˚C – 4˚ C (+NaF)
-20˚C – 4˚ C (-NaF)
-20˚C – Room temp. (+NaF)
-20˚C – Room temp. (- NaF)
4˚ C (+NaF) – 4˚ C (-NaF)
4˚ C (+NaF) – Room temp. (+NaF)
4˚ C (+NaF) – Room temp. (- NaF)
4˚ C (- NaF) – Room temp. (+NaF)
4˚ C (- NaF) – Room temp. (- NaF)
Room temp. (+NaF) – Room temp. (- NaF)

p-value
0.3524
0.0000
0.0031
0.0000
0.0000
0.0001
0.0093
0.0001
0.0001
0.0674
0.5000
0.5000
0.0674
0.0674
0.5000
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TFM-OS
Rainbow Trout - Muscle
Treatment comparison
Snap-Frozen – -20˚C
Snap-Frozen – 4˚ C (+NaF)
Snap-Frozen – 4˚ C (- NaF)
Snap-Frozen – Room temp. (+NaF)
Snap-Frozen – Room temp. (- NaF)
-20˚C – 4˚ C (+NaF)
-20˚C – 4˚ C (-NaF)
-20˚C – Room temp. (+NaF)
-20˚C – Room temp. (- NaF)
4˚ C (+NaF) – 4˚ C (-NaF)
4˚ C (+NaF) – Room temp. (+NaF)
4˚ C (+NaF) – Room temp. (- NaF)
4˚ C (- NaF) – Room temp. (+NaF)
4˚ C (- NaF) – Room temp. (- NaF)
Room temp. (+NaF) – Room temp. (- NaF)

p-value
0.1885
0.0001
0.0114
0.0001
0.0001
0.0019
0.0816
0.0019
0.0019
0.0667
0.5000
0.5000
0.0667
0.0667
0.5000

TFM-OS
Rainbow trout - Blood - temperatures
Treatment comparison
Snap-Frozen – -20˚C
Snap-Frozen – 4˚ C
Snap-Frozen – Room temp.
-20˚C – 4˚ C
-20˚C – Room temp.
4˚ C – Room temp.

p-value
0.4464
0.2730
0.0568
0.3176
0.0430
0.0168

TFM-OS
Rainbow trout - Blood - vacutainers
Treatment comparison
Snap-Frozen – Green
Snap-Frozen – Blue
Snap-Frozen – Grey
Green – Blue
Green – Grey
Blue – Grey

p-value
0.9686782
0.2067774
0.3690494
0.4209110
0.6321339
0.9888159

Parent TFM
White Sucker - Liver
Treatment comparison
Snap-Frozen – -20˚C
Snap-Frozen – 4˚ C

p-value
1
.01
133

Snap-Frozen – Room temp.
-20˚C – 4˚ C
-20˚C – Room temp.
4˚ C – Room temp.

<.01
.01
<.01
<.01

Parent TFM
White sucker - Muscle
Treatment comparison
Snap-Frozen – -20˚C
Snap-Frozen – 4˚ C
Snap-Frozen – Room temp.
-20˚C – 4˚ C
-20˚C – Room temp.
4˚ C – Room temp.

p-value
0.7699943
0.9423835
0
0.9297287
0
0

Parent TFM
White sucker - Blood – vacutainer
Treatment comparison
Snap-Frozen – Green
Snap-Frozen – Blue
Snap-Frozen – Grey
Green – Blue
Green – Grey
Blue – Grey

p-value
.46
<.01
.01
<.01
.16
<.01

TFM-OG
White Sucker - Liver
Treatment comparison
Snap-Frozen – -20˚C
Snap-Frozen – 4˚ C
Snap-Frozen – Room temp.
-20˚C – 4˚ C
-20˚C – Room temp.
4˚ C – Room temp.

p-value
0.2991
0.0004
0.0002
0.0000
0.0000
0.4363

TFM-OG
White sucker - Muscle
Treatment comparison
Snap-Frozen – -20˚C
Snap-Frozen – 4˚ C
Snap-Frozen – Room temp.
-20˚C – 4˚ C
-20˚C – Room temp.
4˚ C – Room temp.

p-value
0.1782
0.1667
0.0013
0.4821
0.0000
0.0000
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TFM-OG
White sucker - Blood – vacutainer
Treatment comparison
Snap-Frozen – Green
Snap-Frozen – Blue
Snap-Frozen – Grey
Green – Blue
Green – Grey
Blue – Grey

p-value
0.2933
0.0001
0.0003
0.0008
0.0018
0.3974

TFM-OS
White Sucker - Liver
Treatment comparison
Snap-Frozen – -20˚C
Snap-Frozen – 4˚ C
Snap-Frozen – Room temp.
-20˚C – 4˚ C
-20˚C – Room temp.
4˚ C – Room temp.

p-value
0.1782
0.0003
0.0006
0.0000
0.0000
0.4157

TFM-OS
White sucker - Muscle
Treatment comparison
Snap-Frozen – -20˚C
Snap-Frozen – 4˚ C
Snap-Frozen – Room temp.
-20˚C – 4˚ C
-20˚C – Room temp.
4˚ C – Room temp.

p-value
0.4907
0.0496
0.0002
0.0520
0.0003
0.0333

TFM-OS
White sucker - Blood – vacutainer
Treatment comparison
Snap-Frozen – Green
Snap-Frozen – Blue
Snap-Frozen – Grey
Green – Blue
Green – Grey
Blue – Grey

p-value
0.0330
0.0004
0.4458
0.0671
0.0242
0.0003
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Appendix C
Sample sizes: Dose Dependent Changes in the distribution of TFM in Rainbow
Trout Tissues
Liver
TFM Concentration (mg l-1)
0
5.5
11.3
16.5
21.9
21.9
25.3
25.3
31

Dead or alive
Alive
Alive
Alive
Alive
Alive
Dead
Alive
Dead
Dead

Sample size
10
12
15
15
4
10
3
11
14

Muscle
TFM Concentration (mg l-1)
0
5.5
11.3
16.5
21.9
21.9
25.3
25.3
31

Dead or alive
Alive
Alive
Alive
Alive
Alive
Dead
Alive
Dead
Dead

Sample size
10
15
15
15
4
11
3
12
15

Blood
TFM Concentration (mg l-1)
0
5.5
11.3
16.5
21.9
21.9
25.3
25.3
31

Dead or alive
Alive
Alive
Alive
Alive
Alive
Dead
Alive
Dead
Dead

Sample size
10
15
15
15
4
11
3
12
15
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Appendix D
TOP:026.8

December 10, 2016
U.S. Fish and Wildlife Service Marquette Biological Station 3090 Wright
Street Marquette, Michigan 49855 U.S.A.
and
U.S. Fish and Wildlife Service Ludington Biological Station 229 South Jebavy
Drive Ludington, Michigan 49431 U.S.A.
and
Fisheries and Oceans Canada Sea Lamprey Control Centre 1219 Queen Street
East Sault Ste. Marie, Ontario P6A 2E5 Canada

TECHNICAL OPERATING PROCEDURE
PROCEDURE TITLE:
Protocol for investigations of, and responses to unexplained mortality of nontarget
fish
APPLICABILITY:
Protocol applies to all unexplained nontarget fish mortality that coincides with
lampricide applications and cannot be initially attributed to the treatment. The
extent that the procedures are followed is at the discretion of the Treatment
Supervisor.
PRINCIPLE:
To provide a framework for investigations of, and responses to unexplained
nontarget fish mortality that coincides with the use of lampricides.
EQUIPMENT REQUIRED:
See Investigation Equipment Checklist (Attachment 1)
POTENTIAL INTERFERENCES:
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Not applicable
SAFETY:
Wear minimum safety equipment (gloves, boots, apron, and safety goggles).
Insulated gloves are required when handling tanks of CO2 and dry ice.
DISPOSAL:
Minor fish kill Disposal of dead fish (<100) can be done by burying fish in a pit
away from human or animal activity after permission is granted from property
owner. All fish can be disposed in a landfill after they have been double bagged.
Moderate or major fish kill All fish should be disposed in a landfill after they have
been double bagged. Contact the local landfill near the body of water where the
fish kill occurred.
REAGENTS:
Not applicable
DEFINITIONS:
I. Typical Survey Effort Biological surveys are routinely conducted during a
treatment and after the lampricide block has passed in order to assess
treatment effectiveness, verify sea lamprey distribution and age class
structure where assessments are questionable, or document nontarget
mortality. Typically, staff walk a stream and collect organisms using scap
nets (Fyke nets are not recommended). Nontarget organisms are identified
to species and sea lampreys are counted and measured. Survey types and
detailed procedures are contained in TOP:029.x.
II.

Fish Kill The American Public Health Association (APHA) et al. (1985)
definitions for levels of impact on fish are used for all fish except lampreys.

A.

Minor kill is defined as <100 fish/1.6 km (1.0 mi.)

B.

Moderate kill is defined as 100 - 1000 fish/1.6 km (1.0 mi.)

C.

Major kill is defined as >1000 fish/1.6 km (1.0 mi.)

III.

Environmental Protection Agency (EPA) Threshold for Nontarget
Organisms Killed Involves any incident caused by a pesticide in Formal
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Review for ecological concerns.
A. Fish: Affected 1,000 or more individuals of a schooling species or 50 or more
individuals of a non-schooling species (AOP:007.x).
PROCEDURES:
The Flowchart for Response to Fish Mortality Concurrent with Lampricide
Treatment (Appendix W) outlines the following procedures in graphical form.
Nontarget fish mortality may be discovered by Sea Lamprey Control Program
(SLCP) field personnel or by personnel external to the program, including the
general public. When the SLCP is notified of fish mortality by a public source the
incident must be confirmed. If notification occurs after the field crew has left the
area, the treatment supervisor may choose to contact another natural resources
agency located in the vicinity of the treatment and ask that they confirm the report.
If there is positive confirmation, the treatment supervisor will determine the
appropriate amount of resources required to respond.
I. Evaluation
A.

Field crew estimates severity and range of the fish kill and determines
whether kill is minor, moderate, or major based on typical chemical
treatment survey effort (See DEFINITIONS).

B.

Field crew identifies species involved

C.

Field crew notifies Treatment Supervisor that a fish kill has occurred

D.

Evaluate potential impacts

1.

Risk to human health

a.

Exposure to disease carrying animals

b.

Exposure to large amounts of decomposing organisms

c.

Nontarget fish kill large enough to affect public activities

2.
a.

Fish population
Spawning stock versus pre-recruited stock
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b.

Species type 1) Valued or non-game species 2) Schooling
or non-schooling (AOP:007.x)

c.

Species sensitive to lampricides

E.

Evaluate immediate response/consider options

1.

Treatment Supervisor determines whether to deploy additional
personnel and resources to assist in nontarget investigation

2.

Treatment Supervisor notifies Unit Supervisor of nontarget fish
kill

II.

Notification

A.

Unit Supervisor decides which agencies or individuals need to be notified
based on consideration of the following: 1. Severity/scope of the
fish kill 2. Species impacted 3. Potential for public concern

B.

Agencies, organizations, and individuals that may require notification

1. Canada
a. Federal agencies 1) DFO 2) Health Canada
b. Provincial agencies 1) Ministry of Natural Resources 2) Ministry of
Environment
c. Local agencies 1) Conservation authorities 2) Municipalities 3) First Nations
d. Great Lakes Fishery Commission 1) Sea Lamprey Program Director 2)
Communications Director
2. United States
a. Federal agencies 1) EPA
2) USFWS (Region 3) (a) Sea Lamprey Control Field Supervisor
b. State agencies c. Local agencies
1) Municipalities 2) County Health Department 3) Native American Tribes
d. Great Lakes Fishery Commission 1) Sea Lamprey Program Director 2)
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Communications Director
III. Investigation
A.
1.

Minor fish kill; follow routine procedures (see TOP:029.x)
Fill out collection forms (Appendices K and M)

a.

U.S. records mortality data on the Larval Assessment Form

b.

DFO records mortality data on the Secondary Application Data
Form

2.

Treatment Supervisor will determine if a 6(a)(2) report is required
(AOP:007.x/US or AOP:007.x/CAN)

B.

Moderate and major fish kill; investigation warranted In addition to actions
taken under minor fish kill, conduct the following:

1.

Quantify numbers of dead nontarget organisms. This task is
accomplished immediately by field personnel using at least one of
the following methods:

a.

Absolute counting method 1) Sample entire area and count all
nontarget fish killed 2) Measure area affected 3) Estimate
collection efficiency

b.

Empirical method of providing estimate based on severity and
range of fish kill (See Attachment 3– Fish Counting
Procedures) 1) Subsample area and count nontarget fish
killed 2) Estimated area affected 3) Estimate collection
efficiency

2.

Collect water samples for toxicant analysis (Attachment 4 - Sample
Collection and Preservation)

a.

Inside the treatment area

b.

In a control area outside of the treatment area

3.

Collect biological samples of fish (Attachment 4 - Sample Collection and
Preservation)
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REFERENCES:
4. Define the stream reach or lentic area in which the fish kill occurred
a.

GPS coordinates

b.

Zone/Station codes

c.

Branch/Lentic

5. Complete the Fish Kill Investigation Packet (Attachment 1) which would
include but is not limited to:
a.

List the species involved

b.

List of contacts 1) Employees involved in the treatment 2) Observers
(General public witnesses)

c.

Possible outside contributing factors 1) Commercial/recreational fishing
2) Fire 3) Toxic algal blooms 4) Lightning 5) Electrofishing (State,
Tribal, Federal, Universities) 6) Ammonia and pesticides from
farming activities

d.

Take photographs of anything suspected of contributing to the fish kill 1)
Area treated 2) Fish killed 3) Shoreline 4) Agriculture 5) Industry 6)
Other boats in the area

6. Compile water chemistry data collected prior to and during treatment which may
include
a.

Temperature

b.

pH

c.

Alkalinity

d.

Dissolved oxygen

e.

Ammonia

7. Compile lampricide application and concentration data collected during
treatment

142

a.

Lampricide application forms

b.

Lampricide analysis forms

c.

Secondary application forms

American Public Health Association, American Water Works Association, and
Water Pollution Control Federation. 1985. Standard methods for the examination
th
of water and wastewater. 16 edition. American Public Health Association,
Washington, D.C. 1268 pp.
Field Manual for the Investigation of Fish Kills. 1990. United States Department
of the Interior, Fish and Wildlife Service/ Resource Publication 177.119 pp.
Queensland Department of Environment and Heritage. 1998. Fish Kill Reporting
and Investigation Manual. QDEH, Brisbane.
Rhode Island Fish Kill Form: http://www.dem.ri.gov/topics/erp/6_4_7.pdf
Southwick, R. I., and A. J. Loftus, editors. 2003. Investigation and Monetary
Values of Fish and Freshwater Mussel Kills. American Fisheries Society, Special
Publication 30, Bethesda, Maryland.
United States Environmental Protection Agency. Reporting Requirements for
Risk/Benefit Information. Federal Register: September 19, 1997 (Vol. 62,
No.182.) http://www.epa.gov/fedrgstr/EPA- PEST/1997/September/Day19/p24937.htm

This procedure has been reviewed and approved by the
undersigned representatives of the U.S. Fish and Wildlife Service
and Fisheries and Oceans Canada.
REVIEWED/APPROVED______________________________
DATE____________ Field Supervisor (U.S.)
REVIEWED/APPROVED______________________________
DATE____________ Division Manager (Canada)
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SAMPLE COLLECTION AND PRESERVATION
Collections are conducted at the discretion of the Treatment Supervisor. The intent
of this section is to provide procedures to collect samples of fish and water in the
event that a fish kill occurs under circumstances where the cause is not obvious.
Data from the analysis of these samples is intended to assist in determining the
cause(s) of the fish kill. Two types of samples will be collected. One set of samples
will be collected for chemical toxicant screening. One set will be collected for
determining if pathogens contributed to the fish kill. Because these data could
potentially be used in litigation, it is critical that the samples be properly collected
and that chain of custody is followed to ensure sample integrity. These procedures
are not required when it is obvious fish mortality is due to lampricide exposure
(toxicity).
I. Collection of samples for chemical toxicant screening
A. Water
1. Collect 200 mL of water from mid-depth at multiple points outside of (control)
and in the treatment area(s) using a suitable grab device (Van Dorn or Kemmerer).
a. If the treatment area is a granular Bayluscide application, collect sample from
each corner and in the center of the plot.
b. If the treatment area is a stream lampricide application, collect samples from
upstream of the main AP (control), in the section of stream where the fish mortality
occurred (upper limit, mid-way, lower limit).
2. Transfer the samples to a suitable container for storage and transport. The
containers should be made of an inert substance (Teflon is preferred). The use of
glass is discouraged because of the potential for breakage on freezing of the sample.
3. Place the samples in a freezer for storage. If it is not possible to immediately place
the samples in a freezer, place them on ice (dry ice preferred) in a cooler until they
can be transferred to a freezer or shipped.
B. Fish blood
1. Samples of approximately 2 mL of blood should be collected with a heparinized
syringe from 20 fish of each species.
a. Caudal Sample
1) Position fish so that the dorsal side is down.
2) Using a heparin syringe (one per fish) position the needle between the anus and
caudal fin (Photo 1).
3) Insert needle until the vertebra is hit.
4) Draw back on the syringe while pulling back the needle until vein is hit and 2 ml
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of blood is drawn. May need to rotate needle to start blood flow.
5) Remove needle and place blood in Teflon tube that is completely wrapped in foil
(Photo 2). Foil protects sample from light degradation.
6) Label sample as a caudal blood sample and record on Incident Synopsis and
Samples Catalogue and Chain of Custody Record forms.
7) Place on ice (dry ice preferred) and deliver to UMESC (FWS) and *** (DFO).
b. Heart Sample
1) Position fish so that the dorsal side is down.
2) Using a heparin syringe (one per fish), position the needle equally between where
the pectoral fins attach (Photo 3).
3) Insert needle and draw back until 2ml of blood is drawn.
4) Remove needle and place blood in Teflon tube that is completely wrapped in foil
(Photo 2). Foil protects sample from light degradation.
5) Label as a heart blood sample and record on Incident Synopsis and Samples
Catalogue and Chain of Custody Record forms.
6) Place on ice (dry ice preferred) and deliver to UMESC (FWS) and *** (DFO).
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